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In the following, most relevant results from the publications 1-4 are briefly described, while 
unpublished data are illustrated in detail. 
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Abstract 
By proteolysis, the enzymatic cleavage of peptide bonds, proteins undergo an irreversible 
posttranslational modification which is used for protein maturation, activation, signaling and cellular 
adhesion. The work of this thesis approaches the role of the extracellular metalloproteases meprin α 
and meprin β in physiological and pathological conditions, especially in skin and inflammation related 
diseases.  
The first part of this thesis addresses the meprin expression in murine skin and their resulting role in 
wound healing and deposition of extracellular matrix in this organ. In contrast to human skin, meprin 
expression in mice was low and the lack of meprin in knock-out mice was not compensated by other 
astacin protease family members. Nevertheless, re-epithelialization of the epidermis in in vivo wound 
healing studies was decreased when both meprin α and meprin β were absent. Furthermore, based on 
previous findings that meprins are over-expressed in fibrotic and hyperkeratotic skin diseases, we 
employed and analyzed mouse models over-expressing meprin β in skin in order to study its 
contribution to the onset of disease. In a genetic mouse model, which is transgenic for the transcription 
factor Fra2, mice develop skin fibrosis over time and indeed over-express meprin β in skin. 
Interestingly, the transcribed meprin β mRNA corresponded to the meprin β’ isoform, which is 
associated with expression in cancer cells and might be differentially translated or stabilized in 
comparison to the normal meprin β mRNA. Since Fra2 as part of the transcription factor complex AP-
1 activates several other genes besides the meprin β gene, mouse models directly over-expressing 
meprin β in skin were generated. Epidermal over-expression of meprin β led to a pigmentary 
phenotype and hyperproliferation of keratinocytes that might derive from local inflammation and cell 
stress through loss of cellular adhesion. On the other hand, a dermal over-expression of meprin β did 
not show an obvious phenotype or development of fibrosis. 
The second part is focused on proteolytic processing of the adhesion molecule CD99, which is a novel 
meprin β substrate. Indeed, cleavage of CD99 by meprin β was observed in in vitro studies and had 
significant effect on transendothelial migration of cancer cells. Furthermore, inhibition of meprin β 
increased CD99 levels in mouse lung and infiltration and migration of immune cells was delayed in an 
acute inflammation model upon meprin β knock-out, thereby strengthening a role for CD99 cleavage 
by meprin β in vivo. 
Finally, altered localization of meprin α was investigated during pathological conditions. Increased 
levels of secreted meprin α were observed in plasma of patients suffering from idiopathic pulmonary 
arterial hypertension. Under normal conditions, soluble meprin α was observed to bind to epithelial 
cells via heparan sulphate, which had impact on infiltration of immune cells and epithelial barrier 
integrity. Moreover, covalent binding of meprin α to meprin β on the secretory pathway could also 
tether soluble meprin α to the plasma membrane. The meprin enzyme complex exhibited enhanced 
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stability and increased activity of the meprin monomers. The altered localization of meprin α also 
influenced gene regulation of epithelial cells and contributed to inflammatory disease progression. 
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Zusammenfassung 
Durch Proteolyse, der enzymatischen Spaltung von Peptidbindungen, werden Proteine irreversibel 
posttranslational modifiziert, was für die Reifung, Aktivierung, Signalwirkung und zelluläre Adhäsion 
von Proteinen notwendig ist. Diese Arbeit befasste sich mit den extrazellulären Metalloproteasen 
Meprin α und Meprin β und ihre Rolle in physiologischen und pathologischen Bedingungen mit 
besonderem Fokus auf haut- und entzündungsbasierten Erkrankungen. 
Der erste Teil dieser Arbeit thematisierte die Expression von Meprinen in muriner Haut, sowie ihre 
potentielle Beteiligung im Wundheilungsprozess und am Aufbau von extrazellulärer Matrix. Im 
Gegensatz zu humaner Haut war die Meprin Expression in Mäusen gering und eine Gendeletion in 
knock-out Mäusen wurde nicht kompensiert durch andere Mitglieder der Astacin-Proteasefamilie. 
Jedoch war die epidermale Reepithelialisierung in in vivo Wundheilungsstudien verringert, wenn 
Meprin α und Meprin β gleichermaßen fehlten. Vorherige Arbeiten konnten zeigen, dass Meprine 
überexprimiert in fibrotischen und hyperkeratotischen Hauterkrankungen vorliegen können. Daher 
haben wir Mausmodelle verwendet und analysiert, die Meprin β in der Haut überexprimieren, um ihre 
Beteiligung zur Entstehung der Krankheiten zu überprüfen. In einem genetischen Mausmodell, 
welches transgen für den Transkriptionsfaktor Fra2 ist, entwickeln Mäuse mit der Zeit eine 
Hautfibrose und zeigen eine Überexpression von Meprin β. Interessanterweise entspricht die 
transkribierte Meprin β mRNA der Isoform Meprin β‘, welche assoziiert ist mit Expression in 
Krebszellen und möglicherweise anders translatiert oder stabilisiert wird als die normale Meprin β 
mRNA. Da Fra2 als Teil des Transkriptionsfaktorkomplexes AP-1 weitere Gene neben dem Gen für 
Meprin β aktiviert, wurden Mausmodelle generiert, die auf direkter Weise Meprin β überexprimieren. 
Durch Überexpression von Meprin β in der Epidermis entwickelten Mäuse einen 
Pigmentierungsphänotyp und eine Hyperproliferation von Keratinozyten, welche möglicherweise 
durch lokale Entzündung und Zellstress durch Verlust von Zelladhäsion entstanden. Im Gegensatz 
dazu zeigte eine dermale Überexpression von Meprin β keinen offensichtlichen Phänotyp oder 
Entstehung von Fibrose. 
Der zweite Teil beschäftigte sich mit der proteolytischen Spaltung des Adhäsionsmoleküls CD99, 
welches als neues Meprin β Substrat in in vitro Studien identifiziert wurde. Die Proteolyse von CD99 
durch Meprin β hatte signifikanten Einfluss auf transendotheliale Migration von Krebszellen. Des 
Weiteren wurden erhöhte CD99 Level in Lungen nach Inhibition von Meprin β gezeigt, sowie eine 
geringere Infiltration und Migration von Immunzellen in einem akuten Entzündungsmodell mit 
Meprin β knock-out Mäusen. Diese Beobachtungen bekräftigen die Spaltung von CD99 durch Meprin 
β im lebenden Organismus. 
Im dritten Teil wurde eine veränderte Lokalisation von Meprin α in pathologischen Bedingungen 
untersucht. Erhöhte Level von löslichem Meprin α wurden im Plasma von Patienten gefunden, die an 
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pulmonaler arterieller Hypertonie erkrankt waren. In normalen Bedingungen wurde beobachtet, dass 
sich Meprin α über Heparansulfat an Epithelzellen anlagert, was Einfluss auf Infiltration von 
Immunzellen und Barrierefunktion des Epithels zeigte. Des Weiteren kann Meprin α auch durch 
kovalente Bindung an Meprin β auf dem sekretorischen Weg an der Zelloberfläche lokalisiert sein. 
Dieser Meprin Enzymkomplex führte zu erhöhter Stabilität und Aktivität der einzelnen Meprin 
Monomere. Die veränderte Lokalisation von Meprin α hatte außerdem einen Einfluss auf 
Genregulation in Epithelzellen und trug zum Verlauf von Entzündungsprozessen bei. 
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1. Introduction 
Proteases are essential regulators of various biological processes in physiological and 
pathophysiological conditions. Unlike other posttranslational modifications like phosphorylation and 
lipidation, cleavage of peptide bonds is irreversible, leading to liberation of signal molecules, 
activation of proteins and their degradation. Dysregulated expression and activity of a single protease 
can therefore lead to disturbances within the tightly regulated protease web. These disturbances 
include decreased or increased substrate shedding, resulting in altered signal transduction and changes 
in cellular morphology or tissue homeostasis. Therefore, knowledge about each protease is crucial to 
understand their specific role in physiological processes and progression of pathologies. 
1.1 Meprin metalloproteases 
Meprin metalloproteases were first discovered in 1981 as a novel metallo-endopeptidase in the brush 
border membrane of murine kidney (Beynon et al., 1981). Later on, an unexpected proteolytic activity 
in the intestine of patients after pancreas surgery revealed meprin expression in the gut (Sterchi et al., 
1982). In the following years, meprin α and meprin β were identified as two individual enzymes 
located on different chromosomes (Gorbea et al., 1993; Jiang et al., 1993). Due to their conserved 
zinc-binding motif (HExxHxxGxxHxxxRxDR) and a Met-turn in close proximity to the active site 
cleft, which includes a tyrosine to further coordinate the zinc ion (Gomis-Rüth et al., 2012), meprins 
were assigned to the family of astacin proteases (Dumermuth et al., 1991). Other family members are 
bone morphogenetic protein 1 (BMP-1), mammalian tolloid (mTLD), tolloid 1 (Tll1), tolloid 2 (Tll2) 
and ovastacin, which share a similar catalytic domain but differ in their overall domain composition.  
Both meprin proteases are type I transmembrane proteins, sharing an equal domain structure 
consisting of a N-terminal pro-peptide, an astacin-like protease domain, a MAM domain (meprin, A5-
protein and receptor protein-tyrosine phosphatase μ) for dimerization of two monomers, a TRAF 
domain (tumor necrosis factor-receptor associated factor) as well as an EGF (epidermal growth 
factor)-like domain, followed by a transmembrane domain and a C-terminal cytosolic tail (Figure 1). 
Unlike meprin β, meprin α possess an inserted domain with a furin cleavage site. During maturation, 
meprin α is shed by furin in the Golgi apparatus, which makes it a secreted protease that can form 
large oligomers up to 6 MDa in size (Bertenshaw et al., 2003; Marchand et al., 1995). Meprin β, on the 
other hand, is transported to the cell surface and can be shed in its inactive form by ADAM proteases 
(Herzog et al., 2014; Wichert et al., 2017). Interestingly, when expressed together, both proteases form 
a disulfide-linked heterodimer, that tethers furin cleaved meprin α to plasma membranes and regulates 
its secretion through shedding of meprin β (Johnson and Hersh, 1992; Marchand et al., 1995). Both 
meprin proteases share a similar cleavage specificity, preferring negatively charged amino acids at the 
P1’ position (Becker-Pauly et al., 2011). The so far identified substrate spectrum includes adhesion 
molecules, growth factors and proteins of the extracellular matrix (Jefferson et al., 2013). Although 
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meprins share 38% amino acid homology in the human isoforms, meprins differ in expression and 
localization, which makes some proteins unique substrates for each meprin. 
 
Figure 1: Domain structure and oligomerization of meprin α and meprin β. 
Meprin metalloproteases are disulfide-linked type I transmembrane enzymes consisting of several domains. Upon furin 
cleavage within its inserted domain (I), meprin α is secreted to the extracellular space subsequently forming large oligomeric 
structures. Meprin β can be shed by ADAMs from the plasma membrane but cannot form oligomers larger than dimers. 
Being expressed together, meprin α and meprin β form heterooligomers that tether meprin α to the plasma membrane. 
(Adapted from (Arnold et al., 2017)). 
Total gene knock-outs in mice can demonstrate the physiological role of the translated protein in vivo. 
For proteases, accumulation of non-cleaved substrates reveals necessary activities of an enzyme in a 
complex organism which cannot be compensated by other proteases. However, compensatory effects 
occur in many cases and are essential for an organism to survive and to not be dependent on one single 
enzyme. Meprin α and meprin β single- as well as double knock-out mice are viable and show no 
alterations in development (Banerjee et al., 2009; Norman et al., 2003). Nevertheless, collagen 
maturation and deposition in the dermis is reduced and resembles an Ehlers-Danlos syndrome-like 
phenotype by decreased tensile strength (Broder et al., 2013). Although meprins are able to maturate 
collagens, other proteases like BMP-1 or ADAMTS could promote reasonable development of skin 
(Kessler et al., 1996; Li et al., 2001, 1996). Furthermore, mucus detachment in the small intestine of 
meprin β knock-out mice is impaired which could lead to mucus accumulation and bacterial 
overgrowth (Schütte et al., 2014; Wichert et al., 2017). Interestingly, missing meprin activity was 
either shown to be beneficial or disadvantageous for an organism in different induced pathological 
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situations. Therefore, research on meprin proteases could be of high interest in the setting of disease 
initiation and progression.  
1.2 Skin, wound healing, fibrosis and psoriasis 
The skin is the largest organ of the body, exhibiting necessary functions like homeostasis, protection 
against environmental assaults, water loss and mechanical traumata. Therefore, the skin undergoes 
constant remodeling which requires a tightly regulated network between cells, extracellular matrix 
(ECM) and signaling molecules. The dermis is the lower part of the two main skin layers, which 
consists mainly of collagen fibers and fibroblasts and harbors the hair follicles. The epidermis 
represents the upper part, which is build up by keratinocytes that finally undergo a special form of cell 
death to build the cornified envelope. Interestingly, human epidermis is made up of several layers of 
differentially differentiated keratinocytes while murine epidermis is thin and composed of only 2-3 
cell layers (Figure 2). Additionally, hair roots occupy the majority of the murine dermis and enlarge 
surface area of basal keratinocytes. Despite these anatomical differences, mouse models are widely 
used for research on skin physiology and pathologies in order to understand these mechanisms and the 
complex interplay of different cells and genes in an organism. 
 
Figure 2: Structure of and cellular composition of human and murine skin. 
Skin can be separated into an upper part (epidermis) and lower part (dermis) that are composed of different cells and 
extracellular matrix. While the epidermis of human skin (panel b) shows several layers of differentiating keratinocytes that 
form the cornified envelope, murine epidermis (panel a) consists only of few keratinocyte layers. Additionally, murine skin 
harbors more hair follicles that occupy majority of the dermal layer. (Adapted from (Pasparakis et al., 2014)). 
Cutaneous wound healing is an intricate process that requires coordination of several cell types and 
communication via chemical, biological and physical signals. In brief, a first inflammatory process 
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results in deposition of new extracellular matrix by fibroblasts, wound contraction of myofibroblasts 
and scar formation for restoration of the injured tissue. Normal wound repair can be monitored by 
three overlapping phases: inflammation, tissue formation and tissue remodeling (Figure 3). Upon 
injury, disruption of the vascular network leads to liberation of platelets from the blood stream into 
damaged tissue, thereby sealing the wound by forming a fibrin clot. Platelets also secrete various 
growth factors and cytokines like TGFβ and PDGF that activate dermal fibroblasts and attract 
neutrophils to infiltrate into the wound (Moulin et al., 1998). Neutrophils themselves produce pro-
inflammatory cytokines and ECM degrading enzymes to clear the wound from damaged tissue 
(Hübner et al., 1996; Nwomeh et al., 1998). For proper re-epithelialization, keratinocytes from the 
wound edge have to migrate over the provisional matrix to form a new epidermal layer. This process 
requires reorganization of the intracellular cytoskeleton and dissolution of desmosomal and 
hemidesmosomal linkages (Goliger and Paul, 1995). Furthermore, infiltrating macrophages promote 
neovascularization of the tissue and activated fibroblasts deposit new collagen fibrils (Okuno et al., 
2011; Xue and Jackson, 2015). Lastly, under mechanical stress, fibroblasts differentiate to 
myofibroblasts that express smooth muscle actin for contraction and closure of the wound (Tomasek et 
al., 2002). Critical steps are infection and ongoing inflammation, leading to persistence of cytokines, 
large amounts of fibroblasts and myofibroblasts and excessive ECM deposition. The results are 
fibrotic lesions like keloids and hypertrophic scars that remain in the skin (Tredget et al., 1997). 
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Figure 3: Wound healing cycle. 
Upon injury, normal skin homeostasis is disrupted. Platelets from the blood stream are activated and seal the wound by a 
fibrin clot. Inflammatory cells are recruited to the wound and secrete cytokines and chemokines that promote proliferation of 
cells and deposition of extracellular matrix. After wound closure, inflammatory cells are removed and tissue is remodeled for 
scar formation. Persisting inflammation can lead to chronic wounds, excessive ECM deposition and fibrosis. (Adapted from 
(Shechter and Schwartz, 2013)). 
Another chronic skin disease is psoriasis that represents many similarities to wound healing like 
keratinocyte hyperproliferation, inflammatory infiltration and neovascularization (Nickoloff et al., 
2006). Mainly, psoriatic skin lesions originate from dysregulated cross-talk between innate and 
adaptive components of the immune system with resident skin cells (Boehncke and Schön, 2015). This 
includes excessive production of pro-inflammatory cytokines like TNFα and interleukins as well as 
growth factors and antimicrobial peptides that promote infiltration of immune cells and a chronic skin 
inflammation. However, the cause of psoriasis is not fully understood and cures remain elusive. 
Of note, remodeling of the skin in physiological and pathological processes requires expression and 
activity of proteolytic enzymes that promote ECM deposition, cell proliferation and migration as well 
as maturation of cytokines and growth factors (Mezentsev et al., 2014). Therefore, investigation of the 
complex interplay of various enzymes and their role in these processes is crucial for understanding the 
development of pathologies from physiological mechanisms. However, transcription and regulation 
through activation and inhibition as well as single substrates of each protease within the proteolytic 
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web are not fully understood. Genetic models in vitro and in vivo could shed light on the physiological 
and pathological role of each enzyme. 
1.3 Meprin expression in skin and fibrotic conditions 
The metalloproteases meprin α and meprin β were identified to be expressed in both epidermis and 
dermis of human skin (Becker-Pauly et al., 2007; Kronenberg et al., 2010). Interestingly, distribution 
of the proteases within the epidermis is different, indicating specific functions for each meprin in 
keratinocyte differentiation and development. Meprin α is found in the stratum basale, a region of 
undifferentiated and proliferative keratinocytes. Therefore, meprin α might promote proliferation due 
to cleavage of growth factors, proteases and inhibitors or lead to detachment of basal keratinocytes 
from the basement membrane  (Jefferson et al., 2013). Meprin β, on the other hand, is expressed in the 
outer part of the epidermis, the stratum granulosum, where keratinocytes undergo flattening and lose 
their nucleus to form the cornified envelope. Upon activation by kallikrein related peptidases (KLK), 
meprin β might process adhesion molecules like desmogleins, E-Cadherin and CD99 to promote 
desquamation of the keratinocytes (Bedau et al., 2017a; Huguenin et al., 2008; Jefferson et al., 2013; 
Ohler et al., 2010). Of note, in hyperproliferative skin diseases, such as Netherton Syndrome and 
psoriasis, meprin α was found to be expressed in the stratum granulosum and meprin β in the stratum 
corneum (Becker-Pauly et al., 2007). Additionally, upregulation of meprins in the dermis was 
observed in keloids, characterized by hyperproliferation of fibroblasts and excess deposition of 
extracellular matrix (Kronenberg et al., 2010). So far it is not known, if meprins promote the onset and 
progression of such skin diseases and therefore might be a good candidate for investigation of 
therapeutic treatment. 
Transcription of the Mep1b gene is regulated by different promoter binding sites at the 5’ untranslated 
region (Jiang et al., 2000). Besides promoter binding sites for tissue specific expression in kidney 
(HFH3, CREB, GATA1) and intestine (SI/cdx2 and LPH/cdx2), transcription of the Mep1b gene 
could also be activated by transcription factors of the AP-1 transcription factor complex (AP1/PEA3). 
AP-1 is a heterodimeric complex consisting of Fos (c-Fos, FosB, Fra1, Fra2) and Jun proteins (c-Jun, 
JunB, JunD) to regulate differentiation, proliferation, inflammation and apoptosis (Eferl et al., 2008). 
Downstream targets are proteins of the extracellular matrix like collagens (col1α2) (Chung et al., 
1996) and collagen modifying enzymes like MMP-1 (Wang et al., 2012) and MMP-9 (Mittelstadt and 
Patel, 2012). Especially in skin, AP-1 plays a role in tissue regeneration and is responsible for 
differentiation of keratinocytes (Angel et al., 2001). AP-1 itself is activated by signal transduction of 
TGFβ ligands, which are potent growth factors that influence cell proliferation, differentiation, tissue 
homeostasis, morphogenesis and regeneration (Massagué, 2012). Hence, it regulates synthesis and 
deposition of extracellular matrix, bone formation, vascular remodeling and wound healing. It also 
switches epithelial cells into a mesenchymal migratory phenotype (EMT), necessary for gastrulation, 
embryonic tissue formation and regeneration. Due to this potency, TGFβ enhances also tumor invasion 
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and metastasis and promotes fibrosis. Recently, it has been shown that meprin β expression can be 
upregulated via TGFβ in isolated pulmonary arteries cells (Biasin et al., 2014) as well as A549 lung 
carcinoma cells (Biasin et al., 2017). During the last years, activation of meprin β through Fra2 (Fos-
related antigen 2) was studied in regard to pathological conditions. Over-expression of Fra2 led to 
pulmonary hypertension and early death in Fra2 transgenic mice (Eferl et al., 2008). Interestingly, 
meprin β was identified as the most highly upregulated gene in the lungs and thought to be an 
important mediator of vascular remodeling and developing lung fibrosis in the animal model (Biasin et 
al., 2014). This was further proven by intra-tracheal administration of bleomycin in meprin knock-out 
mice for induction of lung fibrosis, which revealed decreased collagen deposition and tissue density in 
meprin β knock-out mice, highlighting a potential role of meprin β in disease progression (Biasin et 
al., 2017). Besides lung phenotypes, Fra2 transgenic mice develop microangiopathy and skin fibrosis 
by excess extracellular matrix deposition from week 12 to 16 (Maurer et al., 2009; Reich et al., 2010). 
However, expression and the role of meprin β for collagen maturation and the onset of fibrosis have 
not yet been studied in the skin of Fra2 transgenic mice.  
1.4 Meprins as regulators of inflammatory processes and associated pathologies 
Other pathologies and pathology developing mouse models highlighted a meprin contribution to 
several other inflammatory processes (Figure 4A). At their main expression sites in the gut and 
kidney, meprins are transported to the plasma membrane on the apical sites of epithelial cells or 
secreted into the lumen of gut and kidney. During cisplatin or ischemia-reperfusion induced acute 
kidney injury, meprins undergo redistribution to the basolateral site of proximal tubuli thereby 
degrading the basement membrane components like nidogen-1 (Herzog et al., 2007; Walker et al., 
1998). This was further proven in meprin knock-out mice and treatment with the meprin inhibitor 
actinonin (Bylander et al., 2008; Herzog et al., 2015). Other basal laminar components cleaved by 
meprins are collagen IV and fibronectin whose cleavage fragments could either act as chemotactic 
agents or block immune responses (Adair-Kirk and Senior, 2008; Kaushal et al., 1994). Moreover, 
meprins were shown to induce the expression of pro-inflammatory cytokines IL-1β, IL-6 and IL-18 in 
macrophages or to directly activate IL-1β (Gao and Si, 2010; Herzog et al., 2009; Li et al., 2014). On 
the other hand, cytokines can also be deactivated as seen for IL-6 (Keiffer and Bond, 2014). Loss of 
IL-6 deactivation in a DSS-induced colitis model in meprin α knock-out mice led to significant 
increased IL-6 levels and higher systemic inflammation in the intestine, indicating a protective role of 
meprin α in inflammatory bowel disease (Banerjee et al., 2009). Furthermore, high abundance of 
meprin α in serum and urine represents a marker for Kawasaki disease, a systemic vasculitis with 
mucocutaneous inflammation that lead to severe morbidity (Kentsis et al., 2013). 
Overall, these data implicate that dysregulated expression and localization of meprins could be 
associated with the onset and progression of inflammation and fibrotic conditions (Figure 4A, B). 
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Figure 4: Contribution of meprin metalloproteases to inflammatory processes, ECM remodeling and 
pathologies. 
(A) Up- and downregulation of meprin metalloproteases by transcription or posttranslational modifications can be associated 
with different (patho)physiological conditions. (Adapted from (Prox et al., 2015)). (B) Expression and localization of meprin 
metalloproteases can regulate inflammatory processes through induction of pro-inflammatory signals and invasion of 
immune cells. Furthermore, remodeling and deposition of ECM can promote development of pathologies or alter the 
environment of migrating and proliferating cells, e.g. cancer cells. (Adapted from (Arnold et al., 2017)). 
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1.5 Aim of the study 
Meprin metalloproteases represent interesting enzymes because of their unique cleavage specificity 
and transcriptional regulation. Besides their expression in kidney and intestinal epithelial cells in 
normal organism physiology, various studies highlight roles of meprins in the onset and progression of 
pathologies. These include not only altered localization at their main expression sites but also 
transcription and translation in other tissues and cells like cancer cells. 
Aim of the study was to further strengthen the role of meprins in the onset of pathologies with regard 
to transcriptional regulation, localization and substrate cleavage of the proteases by in vitro and in vivo 
experiments. Therefore, meprin expression should be investigated in murine skin and their role in the 
process of wound healing. To further elucidate the role of meprin β in the onset of skin fibrosis and 
other skin diseases, mouse models were examined that either express meprin β via the transcription 
factor Fra2 or by direct over-expression in dermis and epidermis. Moreover, cleavage of the novel 
meprin β substrate CD99 was analyzed and its impact on transendothelial migration of inflammatory 
cells and cancer cells. Lastly, localization of secreted meprin α to plasma membranes via heparan 
sulphate or in an enzyme complex with meprin β was investigated with regard to potential roles in 
epithelial barrier function and gene expression alterations. 
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2. Materials and Methods 
Chemicals were purchased from Carl Roth if not indicated otherwise. Ultrapure water was produced 
by Milli-Q® Integral water purification system and is abbreviated with ddH2O. 
2.1 Buffers 
All buffers used in this study are listed in Table 1. 
Table 1: Composition of buffers 
Buffer Composition 
Agarose gel 1-2% (w/v) agarose, 1x TAE buffer, Ethidium bromide 
Blocking solution 3% (w/v) BSA or 5% (w/v) skimmed milk, TBS 
Coomassie 
destaining 
10% (v/v) glacial acetic acid, 40% (v/v) MeOH, 50% (v/v) ddH2O 
Coomassie staining 0,1% (w/v) Coomassie R250, 10% (v/v) glacial acetic acid, 40% (v/v) 
MeOH, 50% (v/v) ddH2O 
Lysis buffer PBS pH 7.4, 1% (v/v) Triton X-100, Complete Protease inhibitor cocktail 
tablet (Roche) 
Lysis buffer (skin) 50 mM Tris-HCl pH 6.8, 150 mM NaCl, 1% (v/v) Triton X-100, 1% (w/v) 
SDS, 2 mM EDTA, Complete Protease inhibitor cocktail tablet (Roche) 
PBS 135 mM NaCl, 2.7 mM KCl, 9.2 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4 
Fixation buffer 4% (w/v) PFA, PBS 
Sample buffer 2.5 ml Tris-HCl pH 6.8, 1 g SDS, 2.5 ml ddH2O, 0.05 g Bromophenol blue, 
5 ml Glycerol, 100-200 mM DTT 
SDS running buffer 25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS, pH 8.3 
Resolving gel buffer 1.5 M Tris, 0.4% (w/v) SDS, pH 8.8 
Stacking gel buffer 0.5 M Tris, 0.4% (w/v) SDS, pH 6.8 
TAE buffer 40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.0 
Tank blot buffer 25 mM Tris, 200 mM Glycin, 20% (v/v) methanol, pH 8.3 
TBS 20 mM Tris, 137 mM NaCl, pH 7.5 
 
2.2 Cell culture 
HaCaT keratinocyte cell line and isolated murine skin fibroblasts were cultured in DMEM + 
GlutaMAX (Gibco, Thermo Fisher Scientific), supplemented with 10% heat-inactivated FCS, 100 
units/ml penicillin, 100 μg/ml streptomycin (Gibco, Thermo Fisher Scientific) and 5 µg/ml 
gentamycin (Carl Roth). Isolated murine keratinocytes were cultured in CnT-57 (CellnTec), 
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supplemented with 100 units/ml penicillin, 100 μg/ml streptomycin (Gibco, Thermo Fisher Scientific) 
and 5 µg/ml gentamycin (Carl Roth). Culture conditions were under a humidified atmosphere (5% 
CO2) at 37°C. 
2.3 Isolation of primary murine keratinocytes and fibroblasts 
Mice were sacrificed and the tail was dissected and disinfected for 5 min in povidone iodine 
(Betaisodona, Mundipharma) followed by 3 washes in 70% ethanol. Under the laminar flow hood, the 
skin was cut with a sterile scalpel and forceps, removed from the bone and divided into three pieces. 
Facing the dermis downwards, the skin was placed on sterile filter paper and incubated with 1% 
trypsin/DMEM at 37°C for 1 h. In the meantime, 10 cm culture dishes were coated with 5 µg/cm² 
Collagen I from rat tail (Gibco, Thermo Fisher Scientific). Collagen I was diluted in 20 mM acetic 
acid and transferred into culture dishes. The dishes were incubated for 1 h at room temperature, 
washed three times with DPBS to remove the acid and directly used or stored at 4°C. After trypsin 
incubation, the epidermis was removed from the dermis by forceps, rinsed with 10% FCS/PBS and 
grinded through a 40 µm cell strainer for 5 min. The cell suspension was centrifuged at 200 x g for 
5 min, the cell pellet dissolved in CnT-57 and seeded into 10 cm collagen-coated culture dishes. After 
48 h, keratinocytes were washed with DPBS and raised to 90% confluency in CnT-57.  
For fibroblast isolation, the remaining dermis was rinsed with 10% FCS/PBS, cut into small pieces 
and transferred into a microcentrifuge tube with 1 ml Collagenase I (500 U/ml) in 1x HBSS (Thermo 
Fisher Scientific). The tissue was incubated at 37°C for 1-2 h by gentle shaking and centrifuged at 
500 x g for 10 min. The tissue/cell-pellet was dissolved in DMEM with 10% FCS and placed in 10 cm 
culture dishes. After 48-72 h, the detached cells were washed with DPBS and raised to total 
confluency. For longer cultivation, cells were immortalized by transfection of SV-40 plasmid to avoid 
senescence and differentiation to myofibroblasts. 
2.4 Skin lysate preparation 
Mice were sacrificed, the skin shaved and dissected. The skin was snap frozen in liquid nitrogen or 
directly pulverized in a nitrogen cooled mortar. Skin lysis buffer was added to the skin powder and 
incubated for 24 h at 4°C under rolling conditions. Skin lysates were centrifuged at 13.000 rpm, 4°C 
for 30 min and transferred into new microcentrifuge tubes. Total protein concentration was measured 
by BCA assay and 50 µg of denatured skin lysates used for SDS-PAGE and Western Blot analysis. 
2.5 Cell lysis, SDS-PAGE and Western blot analysis 
Cells were transfected and incubated for 24 h, harvested and lysed in lysis buffer containing 1% Triton 
x-100/PBS and protease inhibitor tablet with EDTA (Roche). Protein concentration was measured 
using BCA assay (Thermo Fisher Scientific). 30 µg total protein cell lysate or 50 µg tissue lysate were 
separated by SDS-PAGE and transferred by tank-blotting onto nitrocellulose membranes (GE 
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Healthcare) with constant current of 800 mA (4 membranes) or 250 mA (2 membranes). Membranes 
were blocked with 5% milk in Tris-buffered saline (TBS) for 1h at room temperature, incubated 
overnight with primary antibody in milk at 4°C, washed 3x with TBS and incubated with horseradish 
peroxidase-conjugated secondary antibodies in TBS at RT for 1h. After further washes, protein signals 
were detected with SuperSignal West Femto (Thermo Fisher Scientific) in a chemiluminescence 
detection system (LAS-3000, Fujifilm). 
Table 2: Primary antibodies for Western blot analysis 
Primary Antibody Species Dilution Supplier 
HA-Tag Rabbit 1:1000 Cell Signaling Technology 
Mepβ Tier 2 Rabbit 1:1000 Pineda Antibody Service 
LF-68 (Col I, C-
telopeptide) 
Rabbit 1:1000 Larry W. Fisher 
LF-42 (Col I, C-pro-
peptide) 
Rabbit 1:1000 Larry W. Fisher 
α-SMA Mouse 1:1000 Dako 
Cytokeratin 14 (ab7800) Mouse 1:100 (2 µg/ml) Abcam 
Cytokeratin 5 (ab52635) Rabbit 1:10000 Abcam 
E-Cadherin Rabbit 1:1000 Abcam 
CD99, murine Goat 1:500 Dietmar Vestweber, Max Planck 
Institute of Molecular Biomedicine, 
Münster, Germany 
β1 integrin Rabbit 1:5000 Prof. Reinhard Fässler, Max Planck 
Institute of Biochemistry, Munich, 
Germany 
Desmoglein 1 (ab124798) Rabbit 1:1000 Abcam 
Desmoglein 3 (ab14416) Mouse 1:200 Abcam 
 
Table 3: Secondary antibodies for Western blot analysis 
Secondary Antibody Species Dilution Supplier 
α Rabbit IgG-HRP Goat 1:20000 Jackson ImmunoResearch 
α Mouse IgG-HRP Sheep 1:20000 Jackson ImmunoResearch 
α Goat IgG-HRP (sc-2020) Donkey 1:10000 Santa Cruz Biotechnology 
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2.6 RNA isolation from murine skin and primary cells 
RNA was isolated using NucleoSpin® RNA Isolation Kit (Macherey-Nagel) with additional lysation 
steps for murine skin. Mice were sacrificed, dorsal skin was excised and grinded to powder in a liquid 
nitrogen cooled mortar. Skin powder was transferred into a microcentrifuge tube with 350 µl Buffer 
RA1 supplemented with 1% Triton-X-100 and 3.5 µl β-mercaptoethanol. 590 µl RNase-free water and 
10 µl Proteinase K were added, mixed by pipetting and incubated at RT for 10 min followed by 55°C 
for 10 min. Tissue lysates were centrifuged for 3 min at 10,000 x g and the supernatant transferred into 
a new microcentrifuge tube. 475 µl 99% ethanol were added, lysates mixed by vortexing and 
transferred into an RNA binding column (blue ring). After centrifugation at 8.000 x g for 30 s, sample 
preparation was continued as described in the manufacturer’s protocol. RNA was stored at -80°C. 
2.7 cDNA synthesis from RNA samples 
Isolated RNA was transcribed into stable cDNA by using RevertAid First Strand cDNA Synthesis Kit 
(Thermo Fisher Scientific). 1 µg total RNA was incubated with 1 µl Oligo (dT)18 primer in 12 µl total 
volume for 5 min at 65°C. Samples were chilled on ice and treated with 4 µl 5X Reaction Buffer, 1 µl 
RiboLock RNase Inhibitor (20 U/µl), 10 mM dNTP Mix and 1 µl RevertAid M-MuLV RT (200 U/µl). 
After an incubation of 60 min at 42°C, reaction was terminated by heating at 70°C for 5 min. cDNA 
samples were stored at -80°C or used for RT-PCR. 
mRNA levels can be detected and quantified using semi-quantitative or quantitative RT-PCR with 
specific primer pairs for genes of interests.  
2.8 Semi-quantitative RT-PCR from murine and human RNA samples 
For semi-quantitative RT-PCR, cDNA is amplified in a PCR machine and analyzed via agarose gel 
electrophoresis. Gene specificity is ensured by specific primer pairs that target intron spanning regions 
of genes and produce PCR products of a specific length. Amplification of a house keeping gene, e.g. 
GAPDH or β-actin, can be used to estimate total amounts of the gene of interest.  
Table 4: Pipetting scheme for semi-quantitative RT-PCR 
Reagent Volume in µl 
Template cDNA 1 
Forward primer (10 µM) 1 
Reverse primer (10 µM) 1 
dNTP Mix (2 mM) 2 
10x DreamTaq Buffer 2 
DreamTaq Polymerase 0.5 
ddH2O 12.5 
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Table 5: Primer pairs used for semi-quantitative RT-PCR 
Primer Sequence 
mMepA Frag2 For 5’-GCC CAG AGG CCT CCT TCT G-3’ 
mMepA Frag2 Rev 5’-AGA TCA AGC CAG CGA TGC-3’ 
mMepB Frag2 For 5’-CAG TCC TCC ATT TTA TTC TTC-3’ 
mMepB Frag2 Rev 5’-GTT CCG TTA GGG AAA ACA TCC-3’ 
mGAPDH For 5’-CAT TGA CCT CAA CTA CAT GG-3’ 
mGAPDH Rev 5’-AAT GCC AAA GTT GTC ATG GA-3’ 
mBMP1 For 5’-AGC CTG AGC CAG TCC TGG CT-3’ 
mBMP1 Rev 5’-TGG AAC TTC ACC AGG ACA GA-3’ 
mTll1 For 5’-TAT GTG GCA GCA AGA TAC CA-3’ 
mTll1 Rev 5’-GCC ACA TCT CCA ATT GAA TAG A-3’ 
mTll2 For 5’-GCT CCC GTG CAG TAC CGC AT-3’ 
mTll2 Rev 5’-CCT CTG CAC TGC TGA TCT TG-3’ 
mMepB UTR For 5’-TTG CAG CTT TCG TCT GGA-3’ 
mMepB’ Exon3 For 5’-GAC GGG ATG TAC ATG ATG-3’ 
mMepB Exon6 Rev 5‘-TGA ACA CTG AGA TAT AGT-3’ 
 
Table 6: PCR program for semi-quantitative RT-PCR 
Step Temperature Time 
Initial denaturation 95°C 5 min 
Denaturation 94°C 60 sec 
Annealing 55°C 30 sec               30 cycles 
Elongation 72°C 60 sec 
Final elongation 72°C 10 min 
Cooling 4°C hold 
 
6x DNA Loading Dye (Thermo Fisher Scientific) was added and samples loaded on a 1.5% agarose 
gel containing ethidium bromide for detection. Gel electrophoresis was performed at constant voltage 
of 100 V for 35 min and DNA fragments were visualized at a UV-transilluminator (Intas Science 
Imaging). 
2.9 Quantitative RT-PCR (qPCR) from murine and human RNA samples 
For qPCR analysis, cDNA was amplified in the LightCycler®480 II Real-Time PCR System (Roche 
Applied Science) according to the manufacturer’s instructions. In order to ensure specificity for target 
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gene amplification, primer pairs were generated using Universal ProbeLibrary Assay Design Center 
(http://qpcr.probefinder.com/roche3.html). During amplification, specific UPL probes bind to intron 
spanning regions of the gene of interest. Degradation of the UPL probes by the DNA polymerase leads 
to release of fluorescent dyes from quenchers, which is measured by the PCR machine. Relative 
amounts of the target gene were normalized to the house keeping gene GAPDH. 
Table 7: Pipetting scheme for qPCR 
20x Assay Volume in µl 
Forward Primer (100 µM) 1.2 
Reverse primer (100 µM) 1.2 
UPL Probe 4 
ddH2O 13.6 
 
Table 8: Primer pairs used for qPCR 
Primer UPL probe Sequence 
mMepB #97 For #97 5’-AGA CCC AAC GAT GAC CAG TG-3’ 
mMepB #97 Rev 5’-GTT CCG TTA GGG AAA ACA TCC-3’ 
mMepA #107 For #107 5’-GGC ACC TGT GTG AAC GTA AA-3’ 
mMepA #107 Rev 5’-AGA TCA AGC CAG CGA TGC-3’ 
mACTA2 #58 For #58 5’-CTC TCT TCC AGC CAT CTT TCA T-3’ 
mACTA2 #58 Rev 5’-TAT AGG TGG TTT CGT GGA TGC-3’ 
mCol1a2 #71 For #71 5’-CAA GCA TGT CTG GTT AGG AGA G-3’ 
mCol1a2 #71 Rev 5’-AGG ACA CCC CTT CTA CGT TGT-3’ 
mTYR #46 For #46 5‘-CAC CAT GCT TTT GTG GAC AG-3’ 
mTYR #46 Rev 5‘-GGC TTC TGG GTA AAC TTC CAA-3’ 
mKRT5 #22 For #22 5‘-CAG AGC TGA GGA ACA TGC AG-3’ 
mKRT5 #22 Rev 5’-CAT TCT CAG CCG TGG TAC G-3’ 
mKRT14 #22 For #22 5’-CCT CTG GCT CTC AGT CAT CC-3’ 
mKRT14 #22 Rev 5’-GAG ACC ACC TTG CCA TCG-3’ 
mKRT10 #9 For #9 5’-CGA AGA GCT GGC CTA CCT AA-3’ 
mKRT10 #9 Rev 5’-GCA GCG TTC ATT TCC ACA-3’ 
mTgfb1 #72 For #72 5’-TGG AGC AAC ATG TGG AAC TC-3’ 
mTgfb1 #72 Rev 5’-GTC AGC AGC CGG TTC CCA-3’ 
mDSG1 #18 For #18 5’-GCT CAT CAT GGG GTT CCT AGT-3’ 
mDSG1 #18 Rev 5’-CCC CTC CAC AAT CAC AGC-3’ 
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mDSG3 #82 For #82 5’-GAT GAG GAC ACG GGT AAA GC-3’ 
mDSG3 #82 Rev 5’-ACC ATC ATT ACG ACC CAG GA-3’ 
mCD207 #74 For #74 5’-TGT CCT CAG AAT CGG AAC AA-3’ 
mCD207 #74 Rev 5’-TTG GTA AGT CCA ATC CAG TGT G-3’ 
mIL6 #6 For #6 5’-GCT ACC AAA CTG GAT ATA ATC AGG A-3’ 
mIL6 #6 Rev 5’-CCA GGT AGC TAT GGT ACT CCA GAA-3’ 
mAdgre1 #42 For #42 5’-GGA GGA CTT CTC CAA GCC TAT T-3’ 
mAdgre1 #42 Rev 5’-AGG CCT CTC AGA CTT CTG CTT-3‘ 
mIL18 #46 For #46 5‘-CAA ACC TTC CAA ATC ACT TCC T-3’ 
mIL18 #46 Rev 5‘-TCC TTG AAG TTG ACG CAA GA-3’ 
mIL1b #38 For #38 5’-AGT TGA CGG ACC CCA AAA G-3’ 
mIL1b #38 Rev 5’-AGC TGG ATG CTC TCA TCA GG-3’ 
 
20x assay was prepared for gene specific amplification, diluted in ddH2O and transferred in 384 well 
plate. 0.5 µl of transcribed cDNA were mixed with 2x Probes Master (Roche Diagnostics) and added 
to the specific assay sample. qPCR war performed using LightCycler®480 II (Roche Applied 
Science). Relative amounts of target genes were normalized to the housekeeping gene GAPDH. 
2.10 Scratch wound healing assay 
1.5 x 105 HaCaT cells were seeded into 24-wells and grown 48 h to total confluence. Cells were 
washed with PBS and serum starved in DMEM overnight. On the next day, a cross-shaped scratch was 
inflicted to the monolayer. After another washing step for removal of detached cells, 500 µl serum-
free DMEM were added supplemented with indicated inhibitors or recombinant protease. Images of 
the scratch were taken at 0 h and 24 h with Leica DMi8 microscope. Wound areas were analyzed using 
ImageJ MRI_Wound_Healing_Tool. 
For primary murine keratinocytes, 1.5 x 105 cells were seeded into 24-wells and grown overnight to 
total confluence in basal keratinocyte medium (CnT-57, CellnTec). A cross-shaped scratch was 
inflicted to the monolayer and detached cells were removed by PBS washing. 500 µl of CnT-57 were 
added and images taken at 0 h, 24 h and 48 h with Leica DMi8 microscope. Wound areas were 
analyzed using ImageJ MRI_Wound_Healing_Tool. 
2.11 Meprin β activity assay 
Meprin β activity in cell supernatant of isolated primary keratinocytes was measured by fluorogenic 
peptide cleavage assay using a specific meprin β peptide substrate (mca-EDEDED-K-ε-dnp; 
Genosphere Biotechnologies) in a final concentration of 10 µM. The peptide consists of a fluorophore 
(7-methyloxycoumarin-4-yl (mca)), a substrate peptide for meprin β (EDEDED) and a quencher (K-ε-
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2,4-dinitrophenyl (dnp)). 200 µl cell supernatant were incubated with 10 µg/ml trypsin at 37°C, 
30 min for meprin β activation. 1 µM F2 inhibitor were added after 20 min for meprin β inhibition. 
After addition of the fluorogenic peptide, changes in fluorescence intensity were measured every 30 s  
at 37°C for 120 min using a fluorescent spectrometer Infinite F200 PRO (Tecan) with excitation at 
320 nm and emission at 405 nm. Slope of activity from 3 biological replicates was plotted and used for 
statistical analysis. 
2.12 Experimental animals 
Mice were kept in constant environmental conditions (12h light-dark cycles, temperature) and in an 
IVC (Individually Ventilated Cages) system with food and drinking water ad libitum in accordance 
with the ethical standards set by the National Animal Care Committee of Germany. C57Bl/6N 
wildtype, meprin α-deficient (MepA KO, (Banerjee et al., 2009)), meprin β-deficient (MepB KO, 
(Norman et al., 2003)), meprin α/β double deficient (MepAB) and Fra2 transgenic mice (Fra2 tg, 
(Eferl et al., 2008)) were sacrificed, organs were removed and either snap frozen in liquid nitrogen or 
used for cell isolation. 
2.13 Generation of meprin β knock-in mice 
Meprin β knock-in mice were produced in collaboration with Dr. Ronald Naumann and Dr. Michael 
Haase from Max Planck Institute of Molecular Cell Biology and Genetics in Dresden as described 
before (Karimova et al., 2018). In brief, murine meprin β cDNA was cloned into CAG-cre-IRES-
Rosa26 vector and inserted into Rosa26 locus of C57Bl/6N mice by homologous recombination. 
Homozygous meprin β knock-in (MB-KI) mice were crossed to tamoxifen inducible KRT5tm1.1-
CreERT2 or Col1a2-CreERT2-ALPP mice. For excision of the Stop cassette, mice were either treated 
with tamoxifen-citrate food or normal chow for 4 weeks after genotyping, following treatment with 
normal chow. Tamoxifen-citrate food contained 400 mg/kg and was purchased from Envigo. Mice 
were sacrificed 4 weeks or 8 weeks after the tamoxifen treatment at the age of 12 or 16 weeks, 
respectively. The animal experiment was permitted by corresponding authorities of Schleswig-
Holstein, Germany, (V 242 - 12659/2018 (30-4/18); 22.02.2018).  
2.14 Genotyping of meprin knock-in mice in Rosa26 locus 
For genotyping of meprin knock-in mice, primers were designed for generation of PCR products 
spanning the natural Rosa26 locus or the inserted CAG promoter region. Genomic DNA from mice 
was isolated by digestion of tail biopsies with DirectPCR-Tail (Peqlab Biotechnology GmbH) and 
Proteinase K (0.2 mg/ml, Thermo Fisher Scientific) o/n at 55°C and constant agitation. Proteinase K 
was heat inactivated at 85°C for 1h and samples used as templates for genotyping PCR. 
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Table 9: Primers used for genotyping of Rosa26 locus 
Primer Sequence 
Rosa26 For 5‘-AAA GTC GCT CTG AGT TGT TAT C-3’ 
Rosa26 WT Rev 5‘-GAT ATG AAG TAC TGG GCT CTT-3’ 
Rosa26 TG Rev 5‘-TGT CGC AAA TTA ACT GTG AAT C-3’ 
 
Table 10: Pipetting scheme for Rosa26 genotyping PCR 
Reagent Volume in µl 
Template DNA 2 
Forward primer (10 µM) 1 
Reverse primer WT (10 µM) 1 
Reverse primer TG (10 µM) 1 
dNTP Mix (10 mM) 0.4 
10x DreamTaq Buffer 2,5 
DreamTaq Polymerase 0.5 
ddH2O 16.6 
 
Table 11: Rosa26 genotyping PCR program 
Step Temperature Time 
Initial denaturation 95°C 3 min 
Denaturation 95°C 30 sec 
Annealing 56°C 30 sec               35 cycles 
Elongation 72°C 50 sec 
Final elongation 72°C 10 min 
Cooling 4°C hold 
 
6x DNA Loading Dye (Thermo Fisher Scientific) was added and samples loaded on a 1.5% agarose 
gel containing ethidium bromide for detection. Gel electrophoresis was performed at constant voltage 
of 100 V for 35 min and DNA fragments were visualized at a UV-transilluminator (Intas Science 
Imaging). Expected band sizes of the PCR products were 570 bp for the wildtype allele and 380 bp for 
the transgenic allele. 
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2.15 Genotyping of KRT5- and Col1a2-Cre mice 
Insertion of the tamoxifen-inducible Cre-recombinase in either KRT5- or Col1a2-gene was determined 
via genotyping PCR. 
Table 12: Primers used for genotyping of Cre recombinase 
Primer Sequence 
Col1a2_Cre_for 5’-CAG GAG GTT TCG ACT AAG TTG G-3’ 
Col1a2_Cre_rev 5’-CAT GTC CAT CAG GTT CTT GC-3’ 
Cre general for (KRT5) 5‘-GGT TCG CAA GAA CCT GAT GGA CAT-3’ 
Cre general rev (KRT5) 5’-GCT AGA GCC TGT TTT GCA CGT TCA-3’ 
 
Table 13: Pipetting scheme for genotyping of Cre recombinase 
Reagent Col1a2-Cre PCR 
Volume in µl 
Cre general PCR 
Volume in µl 
Template DNA 2 2 
Forward primer (10 µM) 1 1 
Reverse primer (10 µM) 1 1 
dNTP Mix (10 mM) 0.4 0.4 
10x DreamTaq Buffer 2.5 2.5 
DreamTaq Polymerase 0.5 0.5 
ddH2O 17.6 17.6 
 
Table 14: Specific PCR program for genotyping of Col1a2-Cre 
Step Temperature Time 
Initial denaturation 94°C 2 min 
Denaturation 94°C 20 sec 
Annealing 65°C 15 sec               10 cycles, -0.5°C per cycle 
Elongation 68°C 10 sec 
Denaturation 94°C 15 sec 
Annealing 60°C 15 sec               28 cycles 
Elongation 72°C 10 sec 
Final elongation 72°C 2 min 
Cooling 4°C hold 
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Table 15: PCR program for genotyping of Cre recombinase 
Step Temperature Time 
Initial denaturation 95°C 5 min 
Denaturation 95°C 30 sec 
Annealing 56°C 30 sec               30 cycles 
Elongation 72°C 15 sec 
Final elongation 72°C 10 min 
Cooling 4°C hold 
 
6x DNA Loading Dye (Thermo Fisher Scientific) was added and samples loaded on a 2% agarose gel 
containing ethidium bromide for detection. Gel electrophoresis was performed at constant voltage of 
100 V for 30 min and DNA fragments were visualized at a UV-transilluminator (Intas Science 
Imaging). Expected band sizes of the Col1a2-Cre PCR products were 186 bp and 342 bp for the 
general Cre PCR. 
2.16 Validation of Cre recombinase activity 
Excision of the stop cassette by tissue specific Cre recombinase was determined by PCR from 
genomic DNA of tissue biopsies. 
Table 16: Primers used for validation of Cre recombinase activity 
Primer Sequence 
LoxP For 5’-GGA CAA ACT CTT CGC GGT CT-3’ 
mMep in Rosa26 For 5’-TAG AGA TCA TAA TCA GCC-3’ 
mMepB in Rosa26 Rev 5’-CTC TGT CCC GTT CTG GAA-3’ 
 
Table 17: Pipetting scheme for PCR of Cre recombinase activity 
Reagent Volume in µl 
Template DNA 2 
Forward primer LoxP For (10 µM) 1 
Forward primer mMep in Rosa26 For (10 µM) 1 
Reverse primer mMepB in Rosa26 Rev (10 µM) 1 
dNTP Mix (2 mM) 2 
10x DreamTaq Buffer 2 
DreamTaq Polymerase 0.5 
ddH2O 11.5 
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Table 18: PCR program for validation of Cre recombinase activity 
Step Temperature Time 
Initial denaturation 95°C 5 min 
Denaturation 94°C 60 sec 
Annealing 56°C 30 sec               30 cycles 
Elongation 72°C 90 sec 
Final elongation 72°C 10 min 
Cooling 4°C hold 
 
6x DNA Loading Dye (Thermo Fisher Scientific) was added and samples loaded on a 1% agarose gel 
containing ethidium bromide for detection. Gel electrophoresis was performed at constant voltage of 
110 V for 30 min and DNA fragments were visualized at a UV-transilluminator (Intas Science 
Imaging). Expected band sizes of the excised stop cassette and uncleaved DNA segment were 720 bp 
and 980 bp, respectively. 
2.17 In vivo wound healing experiment with meprin knock-out mice 
In vivo wound healing experiments of meprin knock-out mice was performed by Daniel Kruppa, 
University of Freiburg, Germany. Meprin knock-out mice and corresponding wildtype littermates 
were treated with 4 µg/g Carprofen narcotized by isoflurane. For wounding, skin was shaved and 
excised by two skin punch biopsies of 6 mm diameter on dorsal site. Wound size was measured until 
full healing on day 11. For histological analyses, wound area was excised, fixed in 4% PFA/PBS and 
paraffin embedded. The animal experiment was permitted by corresponding authorities of Baden-
Württemberg, Germany.  
2.18 Histological analyses 
Biopsies of dorsal and ventral skin as well as ears were excised and fixed 24h at 4°C in 4% PFA/PBS. 
Paraffin embedding, sectioning and subsequent azan trichrome and haematoxylin and eosin staining 
was performed by Katrin Neblung-Masuhr (Anatomical Institute, University of Kiel). Fontana-Masson 
staining was performed as described in manufacturer’s protocol (Sigma-Aldrich). Tissue sections were 
analyzed by light microscopy (Leica DMi8 microscope). Thickness of epidermis was measured with 
Leica Application Suite X and mean was calculated from ten different measurements. 
2.19 Immunofluorescence staining of murine tissue 
Paraffin embedded tissue sections were rehydrated, boiled in 10 mM citric buffer (pH 5.5) and 
blocked with 5% FCS/PBS. Primary antibody was diluted in 5% FCS/PBS and applied overnight at 
4°C in a dark, humid chamber. Tissue sections were washed 3 times in PBS for 5 min and incubated 
with secondary antibody for 2 h at room temperature. Excessive secondary antibody was removed by 3 
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washes in PBS. Nuclear staining was performed by 5 min incubation with 1 µg/ml DAPI/PBS, 
followed by 3 washes with PBS for 5 min. Stained tissue was mounted with Faramount Aqueous 
Mounting Medium (Dako). 
Table 19: Primary antibodies used for immunofluorescence staining 
Primary antibody Species Dilution Supplier 
HA-Tag (C29F4) Rabbit 1:1000 Cell Signaling Technology 
mMepβ Goat 1:500 R&D Systems 
α-SMA Mouse 1:100 Dako 
LF-68 (Col I, C-telopeptide) Rabbit 1:1000 Larry W. Fisher 
Melan-A (sc-20032) Mouse 1:50 Santa Cruz Biotechnology 
F4/80 (MCA497R) Rat 1:100 Biorad 
Desmoglein 1 (ab124798) Rabbit 1:250 Abcam 
Desmoglein 3 (ab14416) Mouse 1:500 Abcam 
Cytokeratin 14 (ab7800) Mouse 1:200 Abcam 
E-Cadherin Rabbit 1:500 Abcam 
 
Table 20: Secondary antibodies used for immunofluorescence staining 
Secondary antibody Species Dilution Supplier 
α Rabbit IgG Alexa Fluor® 488 Donkey 1:300 Thermo Fisher Scientific 
α Mouse IgG Alexa Fluor® 594 Donkey 1:300 Thermo Fisher Scientific 
α Goat IgG Alexa Fluor® 488 Donkey 1:300 Thermo Fisher Scientific 
α Rabbit IgG Alexa Fluor® 594 Donkey 1:300 Thermo Fisher Scientific 
α Rat IgG Alexa Fluor® 594 Goat 1:300 Thermo Fisher Scientific 
 
Images were acquired with a confocal laser scanning microscope (FV1000, Olympus). 
2.20 Cytokine array 
Cytokine content in murine skin was identified by Proteome Profiler Mouse XL Cytokine Array (R&D 
Systems). Array was incubated with 200 µg skin protein lysate of two Cre-pos + TAM mice and two 
control mice and further performed as described in the manufacturer’s protocol. Array blots were 
analyzed with Analyze Particles Tool in ImageJ. 
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2.21 Statistical analysis 
All statistical analyses were performed with GraphPad Prism 5 software for one-way ANOVA 
followed by Tukey post-test or two-way ANOVA followed by Bonferroni post-test. Values are 
expressed as mean ± SD. The null hypothesis was rejected at P < 0.05. 
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3. Results 
3.1 Expression and regulation of meprin α and meprin β in murine skin 
Besides kidney and intestinal epithelial cells, the metalloproteases meprin α and meprin β were found 
to be expressed in human epidermis as well as in the dermis of fibrotic skin (Becker-Pauly et al., 2007; 
Kronenberg et al., 2010). However, expression of meprins in murine skin is also crucial to investigate 
the role of the proteases in vivo in different genetic models. To date, only total meprin knock-out 
animals are described in literature and characterized. In these mouse models, loss of both meprin α and 
meprin β lead to a less thickened dermis with reduced tensile strength, mimicking an Ehlers-Danlos 
syndrome-like phenotype (Broder et al., 2013).  
Murine skin of either meprin α-, meprin β- or double knock-out mice was excised and analyzed via 
RT-PCR for meprin expression on RNA level (Figure 5). Faint bands were detected in all genotypes 
with heterogeneous distribution. Signals were also obtained in the knock-out samples since 
transcription from DNA to RNA is not inhibited by addition of the knock-out cassette to gain deletion 
of the translated protein. In order to investigate if other members of the astacin family compensate for 
the loss of meprins, RT-PCR was also performed for BMP-1, Tll1 and Tll2. While BMP-1 and Tll1 
expression was the strongest in the wildtype mice, no signals were detected for Tll2. 
 
Figure 5: Expression of astacin-like proteases in murine skin. 
mRNA was isolated from dorsal skin of meprin knock-out mice and wildtype littermates and transcribed to cDNA. Total 
amounts of astacin-like proteases gene transcripts were specifically amplified by RT-PCR and visualized by agarose gel 
electrophoresis. The housekeeping gene GAPDH served as loading control. NTC = non template control. 
The skin consists mainly of dermal fibroblasts in the dermis and keratinocytes in the epidermis. To 
differentiate between these two cell types and get detailed ideas of meprin expression, cell cultures of 
isolated primary cells were established. RT-PCR for the astacin protease expression in dermal 
fibroblasts revealed stronger signals for meprin α RNA than in whole skin samples with heterogeneous 
distribution in all genotypes (Figure 6A). Interestingly, meprin β RNA showed highest expression in 
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meprin β knock-out conditions, indicating a possible feedback loop between translated protein and 
gene transcription. BMP-1 RNA was transcribed heterogeneously while Tll1 expression showed 
strong signals in all samples. Expression of Tll2 could not be observed in dermal fibroblasts. In 
cultured primary keratinocytes, equal results were obtained for BMP-1, Tll1 and Tll2 as in the 
fibroblasts (Figure 6B). Of note, RT-PCR for meprin α revealed undetectable expression of meprin α 
RNA in keratinocytes. Meprin β, on the other hand, was detected in the knock-out conditions and not 
in wildtype cells, comparable to the fibroblasts. 
 
Figure 6: Expression of astacin-like proteases in primary murine skin fibroblasts and keratinocytes. 
mRNA was isolated from primary murine skin fibroblasts (A) and keratinocytes (B, C) and transcribed to cDNA. Total 
amounts of astacin-like proteases gene transcripts were specifically amplified by RT-PCR and visualized by agarose gel 
electrophoresis. The housekeeping gene GAPDH served as loading control. (C) RT-PCR of meprin β deficient keratinocytes 
and small intestine (SI) samples using primer that flank the neomycin cassette containing exon 7 of meprin β. NTC = non 
template control; SI = small intestine. 
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To generate meprin β knock-out mice, a stop cassette was integrated into exon 7 of meprin β in the 
genome of mice (Norman et al., 2003). The stop cassette terminates translation of the meprin mRNA 
at ribosomes and leads to a shorter, incomplete protein and the gene knock-out. However, transcription 
of the genes and mRNA production is unaffected, leading to signals of knock-out genes in RT-PCR as 
observed for meprin α and meprin β in the cultured primary cells. Primer pairs were generated, 
spanning the exon 7 of meprin β, to exclude transcribed signals in the knock-out conditions. Indeed, 
only in wildtype small intestine and not in the knock-out intestine or keratinocytes, a predicted 300 bp 
signal was obtained (Figure 6C).  
In conclusion, unlike in human skin samples, only a slight expression of meprins and BMP-1 on RNA 
level was detected in murine skin homeostasis while other astacin members did not compensate for 
loss of meprins in knock-out mice. 
3.2 Meprins in wound healing and re-epithelialization in vivo and in vitro 
In normal skin homeostasis, the ECM of the dermis remains in a steady state with quiescent fibroblasts 
and vanishingly low ECM turnover. Since meprins are able to maturate pro-collagen and other ECM 
related proteins and loss of meprins leads to reduced ECM deposition during skin development, they 
could play a role in skin wound healing. After induction of a wound, damaged tissue needs to be 
removed and new matrix has to be deposited by activated fibroblasts and proteases. Moreover, 
keratinocytes have to migrate from the wound edge to restore the epidermal barrier function, 
recognizable as migrating tongue. 
Meprin α-, meprin β- and meprin double knock-out mice and their corresponding wildtype littermates 
were wounded by skin punch biopsies (performed in collaboration with Daniel Kruppa and Dr. 
Alexander Nyström, University of Freiburg). Wound areas were measured every second day and 
revealed no significant changes between all genotypes (Figure 7A). However, meprin α deficient mice 
showed a slight reduction in wound closure until day 5. Furthermore, day 3 wounds were cut out and 
analyzed in detail by histology and immunofluorescence. Staining for keratin 14, a marker of basal 
keratinocytes, visualized the beginning migration of keratinocytes from the wound edge to the inside 
of the wound (Figure 7B, C). The length of the migrating tongue was measured in all genotypes and 
showed reduced re-epithelialization in meprin double deficient mice (Figure 7D). Interestingly, loss of 
either meprin α or meprin β did not alter re-epithelialization compared to wildtype littermates, 
indicating a possible compensatory effect of the retained meprin during wound healing. 
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Figure 7: In vivo wound healing of meprin deficient mice. 
Meprin α-, meprin β-, meprin double knock-out mice and corresponding littermates were wounded by punch skin biopsy. (A) 
Wound area of 2-3 mice per genotype was measured every second day until complete wound healing. No differences between 
all genotypes in wound closure properties were obtained. (B, C) Immunofluorescence staining of keratin 14 in day 3 wounds 
of wildtype (B) and meprin double knock-out mice (C). Red arrows indicate the wound edge and white arrows mark the 
migrating tongue of basal keratinocytes from the wound edge. (D) Quantification of re-epithelialization in day 3 wounds of 
all genotypes, indicating significantly reduced migration of keratinocytes in meprin double deficient mice (n = 3-6). WTA/B 
= wildtype littermates of meprin α/meprin β mice; AKO = meprin α knock-out; BKO = meprin β knock-out; ABKO = meprin 
double knock-out. 
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Since altered re-epithelialization was observed in in vivo wound healing studies of meprin KO mice, 
the role of keratinocytes in wound closure was further analyzed. Therefore, scratch assays with a 
keratinocyte cell line and primary keratinocytes were performed in cell culture. 
First, the human keratinocyte cell line HaCaT was used in an assay supplemented with the meprin 
inhibitor actinonin (Figure 8A, B). After overnight serum starvation, a cross-shaped scratch was 
inflicted to a confluent monolayer. Cells were treated either with actinonin or DMSO control followed 
by microscopic imaging of the scratched areas after 0 h and 24 h. A significant change of cell 
migration and wound healing was obtained in actinonin-treated samples compared to the DMSO 
control (Figure 8B). As actinonin mainly inhibits meprin α and to a lower extent meprin β, the scratch 
assay was repeated using the meprin β specific inhibitor F2 (Figure 8C). Interestingly, no change in 
wound area closure after 24 h was observed implicating that meprin α activity might promote 
keratinocyte migration. As a proof of concept, HaCaT cells were treated with recombinant active 
meprins in different concentrations in another approach (Figure 8D, E). Addition of active meprin α 
decelerated cell migration in a dose dependent manner, which was significant from a concentration of 
100 pM recombinant protein. Activity could be blocked by actinonin, although not to the same level as 
in the control samples. For active meprin β, 1 nM protein decelerated cell migration significantly 
which could be blocked by addition of F2 inhibitor. Here, inhibition of recombinant meprin β by F2 
accelerated cell migration in comparison to the control. In conclusion, inhibition of endogenous 
meprins in HaCaT cells showed retarded cell migration. However, addition of recombinant active 
proteases had the same effects, implicating different functions of meprins in their soluble or 
membrane-bound form. 
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Figure 8: Scratch wound healing assay of HaCaT keratinocytes. 
(A) HaCaT cells were grown to a confluent monolayer and 24 h serum starved. A cross-shaped scratch was inflicted and 
microscopic images were taken at 0 h and 24 h. Cells were treated with actinonin or DMSO control. (B) HaCaT cells  treated 
with 10 µM actinonin showed significant reduced migration properties compared to DMSO-treated cells (n = 12). (C) Meprin 
β inhibition by addition of 100 nM F2 inhibitor showed no altered wound healing properties compared to untreated cells (n = 
12). (D) HaCaT cells showed significantly reduced wound healing properties after treatment with recombinant active meprin 
α in a dose dependent manner. Inhibition with 10 µM actinonin reverted the effect (n = 6). (E) HaCaT cells showed 
significantly reduced wound healing properties when treated with 1 nM recombinant active meprin β. Inhibition with 100 nM 
F2 inhibitor reverted the effect (n = 6). 
In order to compare the results obtained from the HaCaT cells to those of the in vivo wound healing, 
murine keratinocytes were isolated from mouse tail of each meprin knock-out model. Keratinocytes 
were grown to a confluent monolayer in basal keratinocyte medium, a cross-shaped scratch was 
inflicted and microscopic images were taken every 24 h. Interestingly, both meprin α and meprin β 
single knock-out keratinocytes did not show significant changes in wound healing properties 
compared to wildtype cells (Figure 9A, B). The double knock-out cells showed a tendency to 
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increased migration and proliferation in first place, however, the wound area was comparable to 
wildtype cells after 72 h (Figure 9C). 
Conclusively, loss of either meprin α or meprin β had no obvious effect on wound closure. However, 
inhibition of both meprins by the inhibitor actinonin or by genetic knock-out slightly decelerate re-
epithelialization and migration of keratinocytes. 
 
Figure 9: Scratch wound healing assay of primary skin keratinocytes from meprin deficient mice. 
(A-C) A cross shaped scratch was inflicted to a monolayer of primary skin keratinocytes from (A) meprin α-, (B) meprin β-, 
(C) meprin double knock-out mice and corresponding wildtype mice. Wound area was measured every 24 h by bright field 
microscopy and analyzed using ImageJ MRI_Wound_Healing_Tool. No difference in wound healing properties was 
observed through the different genotypes. Data are represented as mean from 3 biological replicates with 6 technical 
replicates.  
3.3 Meprin expression and regulation in meprin β over-expressing mouse models 
Meprins were identified to be upregulated or alternatively distributed in various skin diseases like 
Netherton Syndrome, psoriasis and keloids (Becker-Pauly et al., 2007; Kronenberg et al., 2010). 
However, it is not known if meprin over-expression is a result of the disease progression or if meprin 
itself contributes to the onset of the disease. Therefore, mouse models with altered meprin regulation 
and expression could elucidate the role in pathologic conditions in vivo.  
3.3.1 Meprin β over-expression in the Fra2 transgenic mouse model 
The Fra2 transgenic mouse model was described to develop lung fibroses during a short period of time 
leading to pulmonary hypertension and an early death of mice (Eferl et al., 2008). Of note, Fra2 is a 
transcription factor of meprin β, which was identified as most highly upregulated gene in lung tissue 
of Fra2 transgenic mice (Biasin et al., 2014). Besides the lung phenotype, microangiopathy and skin 
fibrosis develop from week 12 to 16 in Fra2 tg mice resulting in systemic sclerosis (Maurer et al., 
2009; Reich et al., 2010). Meprin β expression in Fra2 tg skin has not yet been investigated or 
associated to the developing skin pathology. 
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Figure 10: Developing fibrosis in dorsal skin of 15 weeks old Fra2 tg mice. 
(A) Azan stained tissue sections of dorsal skin from Fra2 tg mice and wildtype littermates (scale bar = 250 µm). (B) Dermal 
thickness measurements of wildtype and Fra2 tg mice showed increased collagen deposition in Fra2 tg mice (n = 6 with mean 
of 10 measurements per tissue section). (C) Epidermal thickness measurements of wildtype and Fra2 tg mice showed 
enlarged epidermal layer in Fra2 tg mice (n = 6 with mean of 10 measurements per tissue section).  
Dorsal skin of 15 weeks old Fra2 tg and littermate wildtype mice was excised, sectioned and stained 
with azan or hematoxylin and eosin (Figure 10A). Measurements of the dermis and epidermis revealed 
a slight increased thickness in Fra2 tg mice compared to wildtype mice, indicating a developing skin 
fibrosis (Figure 10B, C). Furthermore, RNA was isolated from whole skin specimens. Subsequent 
qPCR revealed significant over-expression of meprin β in Fra2 tg skin to up to 22000 fold compared 
to wildtype mice (Figure 11A). Signals for meprin α could not be observed or were out of range. The 
marker gene for fibrosis progression ACTA2, coding for α-smooth muscle actin (α-SMA), tended to 
be upregulated, and Col1a2, coding for collagen1 α2, was significantly increased (Figure 11B, C). 
Overall, high variability in gene expression of Fra2 tg mice was observed through all individual mice. 
To exclude interference of other cell types than fibroblasts in skin, murine fibroblasts were isolated 
from mouse tail and raised in cell culture. RNA isolation and qPCR for meprins and fibrosis marker 
genes were repeated. Here, meprin β reached up to 600 fold upregulation in Fra2 tg fibroblasts 
compared to wildtype cells (Figure 11D). Meprin α gene expression was not altered in Fra2 tg cells but 
showed a tendency to be downregulated (Figure 11E). On the other hand, fibrosis marker genes 
ACTA2, Col1a2 and TGFb1 were upregulated as observed in whole skin (Figure 11F, G, H). 
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Figure 11: Relative gene expression in wildtype and Fra2 tg skin and isolated skin fibroblasts. 
(A – C) Relative changes in gene expression of (A) Mep1b, (B) ACTA2 and (C) Col1a2 in dorsal skin of wildtype and Fra2 
tg mice showed upregulation of Mep1b and the fibrosis marker genes ACTA2 and Col1a2 in 15 weeks old Fra2 tg mice (n = 
6). (D – H) Relative changes in gene expression of (D) Mep1b, (E) Mep1a, (F) ACTA2, (G) Col1a2 and (H) TGFb1 in 
isolated dermal fibroblasts from wildtype and Fra2 tg mice. Mep1b, ACTA2 and Col1a2 showed upregulation in Fra2 tg cells 
while Mep1a expression levels were not altered (n = 3-4). 
Besides Fra2, other transcription factors could regulate meprin β gene expression. For example, tissue 
specific transcription factors lead to transcription of meprin β in epithelial cells of the intestine and 
kidney. Interestingly, two different meprin β transcripts were identified, depending on tissue or cell 
type (Dietrich et al., 1996; Jiang et al., 2000; Matters and Bond, 1999). A larger meprin β transcript 
variant, meprin β’, was identified in murine and human cancer cells, whose expression could be 
stimulated using retinoic acid or phorbol myristal acetate (PMA). The sequence of meprin β’ has an 
elongated 5’ end but differs between mouse and man. Transcription of the human form starts few base 
pairs upstream, resulting in a larger 5’ untranslated region with no changes in protein sequence. The 
murine meprin β’ RNA is a product of alternative splicing, having 3 unique exons that are not present 
in the normal meprin β transcript (Figure 12A). The translated protein has a different signal peptide 
and altered start of the pro-peptide. The physiological consequences with regard to stability, cellular 
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transport and proteolytic activity of meprin β’ have not yet been investigated. Fra2 is a part of the AP-
1 transcription factor complex and AP-1 transcription factor binding sites were also identified in the 
promoter region of meprin β. Hence, this finding raised the question, which type of meprin β transcript 
originates from AP-1/Fra2 promoter binding. 
 
Figure 12: Alternative splicing of murine meprin β in Fra2 tg mice. 
(A) Proposed mechanism of alternative splicing of murine Mep1b in mouse cancer cells and mouse kidney cells. Exons (β 
and β’) are indicated as boxes, promoter binding sites (P and P’) as circle. Binding sites of primers are marked with arrow 
heads. FP = forward primer, RP = reverse primer. Adapted from (Jiang et al., 2000). (B) RT-PCR for Mep1b splice variants 
revealed alternative splicing in Fra2 tg MEFs and normal meprin β mRNA in small intestine samples. SI = small intestine. 
(C) RT-PCR for Mep1b splice variants revealed production of meprin β’ mRNA in skin of Fra2 tg mice. (D) RT-PCR for 
Mep1b splice variants showed alternative spliced meprin β’ mRNA in Fra2 tg skin fibroblasts. 
Total RNA was isolated from wildtype murine small intestine and Fra2 tg and wildtype murine 
endothelial fibroblasts (MEF). RT-PCR for meprin β and meprin β’ was performed using 3 primers as 
indicated in Figure 12A to discriminate between both transcript variants. In murine small intestine, a 
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PCR product of 388 bp occurred on the gel which corresponded to the expected meprin β transcript 
(Figure 12B). In Fra2 tg MEFs, the PCR product of meprin β’ was detected as 307 bp band while no 
signal was obtained in wildtype MEFs. Furthermore, RT-PCR was repeated using total RNA from 
Fra2 tg and wildtype skin (Figure 12C). Here, faint bands of the meprin β’ transcript were detected in 
three Fra2 tg mice. To exclude interference of other cell types in the skin, RNA from murine 
fibroblasts was also determined (Figure 12D). Again, two of three Fra2 tg fibroblasts showed signals 
of the meprin β’ transcript. Interestingly, a faint band of the 307 bp PCR product was also present in 
small intestine sample. In conclusion, Fra2 promoter binding leads to transcription of meprin β’ in 
murine skin, MEFs and murine dermal fibroblasts. 
3.3.2 Meprin β over-expression in KRT5 expressing cells (KRT5-Cre MB-KI) 
Since over-expression of Fra2 in the Fra2 tg mouse model is not limited to certain cells and organs and 
Fra2 affects many other genes besides meprin β, a new mouse model was established over-expressing 
only murine meprin β. For this, murine meprin β cDNA was fused to a 2x HA-tag and cloned into 
CAGs ROSA Ires vector. Upstream of meprin β, a loxP-site flanked stop cassette prevents translation 
of the protein. Homologous recombination led to insertion of the meprin β construct into the Rosa26 
locus of C57Bl/6N mice, which is highly accessible for transcription, leading to generation of meprin 
β knock-in mice (MB-KI). Meprin β knock-in mice were crossed to KRT5-Cre mice, which express a 
Cre recombinase upon tamoxifen treatment in keratin 5 transcribing cells (KRT5-Cre MB-KI mice). 
An active Cre recombinase is able to excise the stop cassette and causes subsequent meprin β 
translation and over-expression (Figure 13A). 
 
Figure 13: Cloning and integration of Mep1b in Cre mice and scheme of tamoxifen treatment. 
(A) Integration of CAG-Stop-Mep1b-HA cDNA into Rosa26 locus of C57Bl/6 mice. Meprin β knock-in mice were crossed 
to KRT5-Cre mice for epidermis specific expression of Cre recombinase and excision of the Stop cassette. (B) Time scheme 
of tamoxifen treatment and preparation of mice. Mice were divided into four groups by genetic background and feeding. 
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KRT5-Cre positive and negative meprin β knock-in mice were genotyped and either fed a tamoxifen 
diet or normal diet from 4.5 weeks to 8.5 weeks of age. Mice were then sacrificed at the age of 12 or 
16 weeks (Figure 13B). To validate cleavage of the stop cassette and tissue specificity of the Cre 
recombinase, DNA was isolated from skin, lung, heart, liver and stomach of a tamoxifen-treated and 
normal fed Cre positive mouse. A PCR was designed using primer that target the CAG promoter 
region, the meprin β inserted region and a region within the stop cassette (Figure 14A). Analysis of the 
PCR products revealed excision of the stop cassette only in skin of the Cre positive and tamoxifen-
treated mice (Figure 14B). 
 
Figure 14: Activation of meprin β over-expression in skin of KRT5-Cre MB-KI mice. 
(A) RT-PCR scheme for excision of the Stop cassette was performed using primers that bind in the CAG promoter, within 
the Stop cassette and in Mep1b. Cre activity leads to excision of the Stop cassette and amplification of a 720 bp PCR product, 
while an intact Stop cassette would amplify a 980 bp PCR product. (B) RT-PCR for excision of the Stop cassette in different 
tissues of tamoxifen- and normal chow-treated KRT5-Cre MB-KI mice. Deletion of the Stop cassette was only obtained in 
skin of tamoxifen-treated mice. TAM = tamoxifen diet; ND = normal diet. 
After two weeks of tamoxifen diet treatment, Cre positive mice developed a reticulate pigmentation in 
the ears, got a darker tail and lost hair at the ventral site (Figure 15A-E). At later ages, mice lost also 
hair at the dorsal site, developed the reticulate pigmentation and the skin appeared scaly. Interestingly, 
the dermal sheet of Cre positive and tamoxifen fed mouse tails showed also an untypical reticulate 
pigmentation, indicating a possible pigmentary incontinence (Figure 15F). No obvious differences 
were observed between female and male mice. 
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Figure 15: Pigmentary phenotype of tamoxifen-treated KRT5-Cre MB-KI mice. 
(A, B) KRT5-Cre positive, tamoxifen-treated mice developed non scarring hair loss (noncicatricial alopecia) (A) on the 
complete ventral site or (B) on chest height (marked with white arrows). (A, C) Darker tail pigmentation was observed in 
KRT5-Cre positive, tamoxifen-treated mice (marked with black arrow). (D, E) KRT5-Cre positive, tamoxifen-treated mice 
developed a reticulate or mottled pigmentation in the ear (marked with white arrow). (F) Dermal sheet of KRT5-Cre positive, 
tamoxifen-treated mouse tail showed unusual reticulate pigmentation. 
To further investigate the alterations in skin pigmentation, tissue sections of the ears were stained for 
the HA-tag of meprin β (green) and Melan-A (red), a protein involved in biogenesis of melanosomes 
in melanocytes (Figure 16A). Interestingly, meprin β signals were obtained sectional and were not 
distributed throughout the whole epidermis, possibly correlating with the reticulate pigmentation. 
Melanocytes were mainly observed in the dermis of the murine skin. However, the number of 
melanocytes appeared unaltered in all genotypes. In order to investigate whether the 
hyperpigmentation originated from increased melanosome biogenesis, qPCR for tyrosinase mRNA 
was performed, which is an enzyme that catalyzes the melanin production from tyrosine in 
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melanocytes. TYR tended to be slightly upregulated in tamoxifen-treated KRT5-Cre positive MB-KI 
mice (Figure 16B). Moreover, serial sections of dorsal skin and ears revealed elevated melanin 
staining in basal and cornified epidermis, which occurred both in meprin β containing and meprin β 
absent sites (Figure 16C, highlighted by arrow heads). F4/80 staining showed no signals for 
macrophages at those sites, indicating that melanosomes were transported and stored directly in 
keratinocytes and not in macrophages as reported for cases of pigmentary incontinence. 
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Figure 16: Elevated melanin deposition in epidermis at meprin β expressing sites. 
(A) Immunofluorescence staining for HA-Tag meprin β (green) and Melan-A (red) in KRT5-Cre MB-KI ears (scale bar = 
40 µm). (B) qPCR for TYR from dorsal skin revealed no difference between Cre positive and tamoxifen-treated mice. (C) 
Serial section of KRT5-Cre MB-KI ear stained for melanin by Fontana-Masson staining and immunofluorescence for meprin 
β (green) and F4/80 (red). Arrow heads highlight co-localization of melanin and meprin β (scale bar = 100 µm). 
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Primary keratinocytes were isolated from mouse tails for further experiments. Interestingly, less 
keratinocytes from Cre positive, tamoxifen-treated mice were able to adhere to the bottom of the 
culture dish in comparison to control cells in the first place (Figure 17A). However, subsequent 
cultivation of the cells revealed no difference in proliferation or adhesion. Of note, primary Cre 
positive cells showed a darker pigmentation compared to control cells, which was lost over few 
passages of cultivation, confirming the enhanced pigmentation of keratinocytes as observed in tissue 
sections (Figure 17B). In order to validate meprin β expression and enzymatic activity, supernatants 
from cultured keratinocytes were analyzed employing a specific meprin β activity assay (Figure 17C). 
Supernatant samples were either untreated or incubated with trypsin, to activate meprin β. 
Keratinocytes from Cre positive, tamoxifen-treated mice showed significant meprin β activity after 
trypsin activation, which could be inhibited by the meprin β specific inhibitor F2. Only little meprin β 
activity was observed in samples without trypsin activation, indicating low concentrations of meprin β 
activators in cell culture. 
 
Figure 17: Morphology and meprin β activity of isolated KRT5-Cre MB-KI tail keratinocytes. 
(A) Isolated tail keratinocytes from Cre positive, tamoxifen-treated mice show less viability and adhesion to collagen coated 
dishes compared to control cells. (B) Cell pellets from passage 1 cultivated tail keratinocytes. Cells from Cre positive, 
tamoxifen-treated mice appeared showed pigmentation. (C) Meprin β activity was measured in cell supernatants of Cre 
positive, tamoxifen-treated keratinocytes after trypsin activation and inhibited by the meprin β inhibitor F2 (n = 3). 
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In order to elucidate a role of meprin β in progression of hyperproliferation of keratinocytes, epidermal 
thickness of dorsal and ventral skin as well as in mouse ears was analyzed. Interestingly, significant 
thickening of the epidermis and hyperproliferation was observed in Cre positive and tamoxifen-treated 
mice in comparison to all control groups (Figure 18A-D). Consistent with the thickening of the 
epidermis, increased gene expression of cytokeratins 5, 10 and 14 could be observed, demonstrating 
an overall higher amount of keratinocytes in whole skin specimens (Figure 18E-G). In order to 
validate also increased expression of cytokeratins on protein level, Western blot analysis from whole 
dorsal skin was performed. Indeed, cytokeratin 14 levels showed increased expression in meprin β 
over-expression samples in the full length form and an additional 20 kDa C-terminal fragment 
appeared (Figure 18H). The signals for cytokeratin 5 were heterogeneous in all samples, with no 
detectable differences between the genotypes. 
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Figure 18: Meprin β over-expression in epidermis leads to hyperproliferation of keratinocytes. 
(A) H&E stained dorsal skin of Cre-positive, tamoxifen-treated KRT5-Cre MB-KI mice showed thickening of the epidermis 
in comparison to control mice (scale bar = 200 µm). (B – D) Measurements of epidermal thickness of (B) ventral skin, (C) 
dorsal skin and (D) ear revealed significant thickening of the epidermal layer (each data point represents mean of 10 
measurements of one biological replicate). (E – F) Relative changes in gene expression of (E) KRT5, (F) KRT14 and (G) 
KRT10. Expression of KRT14 was significantly increased in Cre-positive, tamoxifen-treated KRT5-Cre MB-KI mice (n = 6-
9). (H) Western blot analysis of dorsal skin lysates for meprin β- and cytokeratin expression. 
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Adhesion molecules play a major role in anchorage of basal keratinocytes to the basal lamina as well 
as for their differentiation, to detach and to form the cornified envelope. Therefore, qPCR was 
performed to analyze gene expression of desmogleins, components of intercellular desmosome 
junctions. Interestingly, desmogleins 1 and 3 showed increased expression in dorsal skin of Cre 
positive, tamoxifen-treated mice compared to control littermates (Figure 19A, B). Of note, meprin β 
was shown to cleave desmogleins in vitro but cleavage of these adhesion molecules for keratinocyte 
differentiation in vivo remained elusive (Jefferson et al., 2013). Western blot analysis of skin lysates 
revealed protein levels of full length desmoglein 1 only in control samples and for desmoglein 3, a 
20 kDa fragment could be observed in Cre positive, tamoxifen-treated mice, indicating possible 
proteolytic processes (Figure 19C). Furthermore, immunofluorescence staining for desmogleins in 
dorsal skin confirmed their expression in the epidermis (Figure 19D). Stronger signals for desmoglein 
1 (green, upper panel) were observed in control mice as seen in the Western blot. However, co-
localization of desmoglein 3 (red, middle panel) and meprin β (green, middle panel) was not visible in 
dorsal skin. Besides desmogleins, expression levels of other adhesion molecules and possible meprin β 
substrates were analyzed. E-Cadherin and meprin β showed high co-localization in hair follicles and 
hair shafts and increased E-cadherin expression was obtained in Cre positive, tamoxifen-treated mice 
by Western blot (Figure 19C, D). Of note, the in vitro characterized 97 kDa E-cadherin cleavage 
fragment produced by meprin β was more pronounced in meprin β over-expressing skin (Huguenin et 
al., 2008). Furthermore, staining for β1 integrin and CD99 was performed. Signals for β1 integrin 
increased and less cleavage fragments were observed in presence of meprin β. For CD99, the full 
length protein was expressed heterogeneously and no fragments of lower molecular weights occurred 
in Western blot (Figure 19C). 
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Figure 19: Meprin β over-expression in epidermis leads to increased expression of adhesion molecules. 
(A, B) Relative changes in gene expression of (A) DSG1 and (B) DSG3 showed production of desmoglein mRNA in skin of 
Cre-positive, tamoxifen-treated KRT5-Cre MB-KI mice (n = 6-9). (C) Western blot analysis of dorsal skin lysates for meprin 
β- and adhesion molecule expression. (D) Immunofluorescence staining for desmoglein 1 and 3, meprin β, E-Cadherin and 
cytokeratin 14 (scale bar = 40 µm). 
Inflammation was shown to result in hyperproliferation of keratinocytes and promotes onset of 
psoriasis (Nickoloff et al., 2007). Therefore, expression of inflammation related genes was analyzed 
from skin samples. The Langerhans cell marker CD207 as well as macrophage marker Adgre1 (F4/80) 
showed increased mRNA expression in dorsal skin of meprin β over-expressing mice (Figure 20A, B). 
This is further supported by more F4/80 positive macrophages observed in skin tissue sections (Figure 
20C), associated with the upregulation of the proliferation inducer TGFβ1 and pro-inflammatory 
cytokines IL-18, IL-6 and IL1b (Figure 20D-G). In order to validate increasing amounts of pro-
inflammatory cytokines on protein level, a proteome profiler cytokine array was performed, analyzing 
111 murine cytokines simultaneously. Astonishingly, total cytokine amounts from two control and two 
meprin β over-expressing mice appeared rather equal (Figure 20H). Nevertheless, some proteins 
differed between both genotypes that were chemoattractants for inflammatory cells (CCL22, CCL11, 
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CCL6), proliferation stimulator of T- and B-cells (CD40) or inhibitors of angiogenesis (endostatin) 
and apoptosis (osteoprotegerin) (Figure 20I). 
 
Figure 20: Regulation of inflammation related markers in KRT5-Cre MB-KI mice. 
(A, B) Relative changes in gene expression of (A) CD207 and (B) Adgre1 showed increased expression of Langerhans cell 
and macrophage markers in skin of Cre-positive, tamoxifen-treated KRT5-Cre MB-KI mice (n = 4-9). (C) 
Immunofluorescence staining of dorsal skin revealed enhanced amount of F4/80 positive macrophages in meprin β over-
expressing skin. (D-G) Relative changes in gene expression of (D) TGFβ1, (E) IL18, (F) IL6 and (G) IL1β showed increased 
expression in skin of Cre-positive, tamoxifen-treated KRT5-Cre MB-KI mice (n = 4-9). (H) Cytokine array blots incubated 
with skin lysate of one control and one Cre pos + TAM mouse. Selected genes for further analysis are highlighted with 
numbers and boxes. (I) Relative expression of selected genes from cytokine array of two control and two Cre pos + TAM 
mice. Numbers can be linked to boxes in (H) (n = 2). 
In conclusion, meprin β was specifically over-expressed in epidermis and hair follicle of KRT5-Cre 
positive mice leading to hyperproliferation of keratinocytes and a pigmentation phenotype. However, 
Results 
49 
 
meprin β expression appeared only partially, which influenced pigmentation, adhesion molecule 
cleavage and probably inflammation at particular sites in the skin. The obtained phenotype probably 
resembles the rare syndromes Dermatopathia Pigmentosa Reticularis (DPR) and Epidermolysis 
bullosa simplex with mottled pigmentation and noncicatricial alopecia (MP-EBS) that originate from 
cytokeratin 5 and 14 loss-of-function mutations (Belligni et al., 2011; Nagai et al., 2016). 
3.3.3 Meprin β over-expression in Col1a2 expressing cells (Col1a2-Cre MB-KI) 
Dermal expression of meprin β was only detectable in human fibrotic skin and not in normal skin 
homeostasis (Kronenberg et al., 2010). Additionally, being highly expressed in fibrotic skin of Fra2 
mice, meprin β might contribute to progression or initiation of dermal fibrosis. To overcome side 
effects and dysregulation of other genes in the Fra2 mouse model, direct over-expression of meprin β 
was induced as described in 3.3.2. Meprin β over-expressing mice were crossed to Col1a2-Cre mice, 
which express a Cre recombinase after tamoxifen treatment in collagen1α2 transcribing cells (Figure 
21A). Therefore, direct over-expression of meprin β in murine dermis could be studied with regard to 
altered ECM deposition and fibrosis development in vivo. 
Col1a2-Cre positive and negative meprin β knock-in mice were genotyped and either fed a tamoxifen 
diet or normal diet from 4.5 weeks to 8.5 weeks of age. At the age of 12 weeks, mice were sacrificed 
and activity of the Cre recombinase analyzed in different tissues by using PCR for excision of the Stop 
cassette (Figure 14A). Faint bands of the excised Stop cassette were observed in skin and stomach of 
Cre positive and tamoxifen-treated mice (Figure 21B). However, low PCR efficiency was obtained 
from some biopsies. Further validation of skin samples of six different mice revealed Stop cassette 
excision only in Cre positive mice (Figure 21C). 
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Figure 21: Activation and phenotype of meprin β over-expression in Col1a2-Cre MB-KI mice. 
(A) Integration of CAG-Stop-Mep1b-HA cDNA into Rosa26 locus of C57Bl/6 mice. Meprin β knock-in mice were crossed 
to Col1a2-Cre mice for dermis specific expression of Cre recombinase and excision of the Stop cassette. (B) RT-PCR for 
excision of the Stop cassette in different tissues of tamoxifen-treated Col1a2-Cre positive and negative MB-KI mice. 
Deletion of the Stop cassette was only obtained in skin of Cre positive and tamoxifen-treated mice. Pos = Cre positive; Neg = 
Cre negative. (C) RT-PCR in skin of Col1a2-Cre positive and negative MB-KI mice revealed PCR fragments of excised Stop 
cassette in Cre positive mice. (D) No obvious phenotype differences were observed in 12 weeks old, tamoxifen-treated 
Col1a2-Cre MB-KI mice. 
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In comparison to KRT5-Cre MB-KI mice, Col1a2-Cre MB-KI did not show an obvious phenotype 
during and after tamoxifen treatment. At 12 weeks of age, fur and pigmentation of sacrificed mice 
appeared normal and no difference in skin thickness was observed (Figure 21D). Dorsal skin was 
excised and analyzed via Azan and H&E staining. Thickness and density of the collagen layer showed 
no apparent variation between Cre positive, tamoxifen-treated mice and the control groups (Figure 
22A). In order to validate over-expression of meprin β on protein level, immunofluorescence staining 
of skin was performed. Indeed, meprin β could be detected in the dermis via its C-terminal HA-tag and 
via a specific antibody, however in a lower amount (Figure 22B, C). Co-localization with collagen1 
and the fibrosis marker α-smooth muscle actin (α-SMA) was not detectable and their amount in the 
skin biopsies appeared unaltered. For better quantification of protein amounts, dorsal skin was grinded 
in a mortar, lysed and analyzed by immunoblot. Meprin β was detectable with an HA-Tag antibody 
and specific meprin β antibody in Cre positive, tamoxifen-treated mouse samples as 125 kDa band 
(Figure 22D). Immunoblot staining for collagen1α1 C-telopeptide resulted in equal amounts of 
maturated collagen I in the skin of all mice, however, less collagen was present in female samples. The 
same effect was seen with an antibody against the C-pro-peptide of collagen I where equal amounts of 
cleaved pro-peptide were present within the genders. Staining for α-SMA appeared only in few 
samples with heterogeneous expression through all individual samples, consistent with the 
immunofluorescence staining of tissue sections. 
Conclusively, meprin β was specifically over-expressed in the dermis of Col1a2-Cre positive mice. 
However, obvious changes towards a developing skin fibrosis were not observed in 12 weeks old 
mice. 
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Figure 22: Analysis of skin sections and lysates of Col1a2-Cre MB-KI mice. 
(A) Azan (left panel) and hematoxylin and eosin staining (right panel) of dorsal skin sections from 12 weeks old Col1a2-Cre 
MB-KI mice and control littermates. (B) Immunofluorescence staining for meprin β (green) and collagen I C-telopeptide 
(red) in dorsal skin sections of Col1a2-Cre MB-KI mice. Expression of meprin β was obtained in Cre positive mice and 
signals for collagen I were heterogeneously distributed. (C) Immunofluorescence staining for HA-meprin β (green) and α-
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SMA (red) in dorsal skin sections of Col1a2-Cre MB-KI mice. Strong meprin β expression was observed in dermal 
fibroblasts that did not co-localized with α-SMA containing myofibroblasts. (D) Western blot analysis from dorsal skin 
lysates of Col1a2-Cre MB-KI mice. Meprin β over-expression was obtained in Cre positive samples. Total amounts of 
collagen I and cleaved C-pro-peptide were unaltered between the genotypes, however reduced in samples of female mice. 
3.4 Cleavage of CD99 by meprin β mediates cell migration of inflammatory cells and cancer cells 
Migration of immune cells is crucial in order to reach all regions of a tissue and to get excess to 
potential inflammatory sites. Immune cells circulate in the vascular system and have to overcome the 
endothelial barrier. Adhesion molecules and their shedding from cell surfaces by proteases play a 
major role for the process of transendothelial migration (TEM). The adhesion molecule CD99 was 
identified as potential meprin β substrate in a proteomics approach, namely terminal amine isotopic 
labeling of substrates (TAILS) (Jefferson et al., 2013). The type I transmembrane protein CD99 is 
expressed on both endothelial cells and cells of the hematopoietic system and forms homophilic 
interactions between both cell types during TEM. Hence, cleavage of CD99 by meprin β might 
promote extravasation of migrating cells into tissue. 
First, a potential processing of CD99 by meprin β was analyzed by incubation of recombinant CD99 
with active recombinant meprin β. Subsequent mass spectrometry analysis revealed that meprin β was 
able to cleave CD99 at several sites within highly conserved regions of acidic amino acids, 
accordantly to the preference of meprin β for negatively charged amino acid residues. Furthermore, 
co-expression of meprin β and CD99 in HeLa cells confirmed cleavage of CD99 at the cell surface, 
resulting in two C-terminal fragments that were further processed by the γ-secretase within the 
transmembrane region (Figure 23A, B). Interestingly, meprin α was not able to shed CD99 from the 
cell surface, both in single transfection and expressed in the meprin enzyme complex (Figure 23C). In 
order to investigate the potential influence on cell migration, an in vitro TEM assay was performed. 
Endothelial bEnd.3 cell were seeded onto transwells to form a confluent monolayer. Afterwards, 
migration of CFSE labelled Lewis lung carcinoma cells (LLC) was measured in presence or absence 
of recombinant active meprin β. Meprin β was able to induce permeability of the endothelial 
monolayer and promoted transmigration of LLCs. To further prove the in vivo relevance of CD99 
shedding by meprin β, CD99 expression was investigated by histology and Western blot in lungs of wt 
and meprin β knock-out mice. Interestingly, meprin β deficient mice exhibited increased levels of 
CD99. As a proof of concept, wt mice showed accumulated CD99 in lungs after daily injection of the 
meprin inhibitor actinonin for one week, indicating processing of CD99 by meprin β in vivo. 
Conclusively, CD99 was confirmed as substrate of meprin β in vitro and in vivo. Shedding of CD99 
resulted in two C-terminal cleavage fragments that were further processed by the γ-secretase, 
producing a smaller fragment that might have intracellular regulatory functions. Furthermore, cleavage 
of homophilic CD99 interaction diminished cell adhesion and promoted TEM (Figure 23D; this was 
published in (Bedau et al., 2017a) and is attached as appendix 1). 
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Figure 23: Cleavage of CD99 by meprin β diminishes cell adhesion and promotes transendothelial cell 
migration. 
(A) Co-transfection of meprin β and CD99 in HeLa cells showed processing of CD99 and production of two CTFs that were 
further cleaved by the γ-secretase complex. (B) Schematic representation of the C-terminally tagged CD99 within the plasma 
membrane. Arrowheads indicate cleavage sites of meprin β and γ-secretase that lead to production of CTF I and CTF II. (C) 
Co-transfection of CD99 with meprin α did not lead to cleavage of CD99 and CTF generation. (D) Schematic model of CD99 
cleavage by meprin β and γ-secretase on endothelial cells, promoting transendothelial migration. (A, B, D) Adapted from 
(Bedau et al., 2017a), appendix 1. (C) Adapted from (Peters et al., in press) appendix 4. 
The role of CD99 shedding by meprin β in vivo was further analyzed by an acute inflammation model 
(air pouch) in meprin β knock-out and wildtype mice. Inflammation was induced by a dorsal air pouch 
followed by injection of carrageenan (Figure 24A). Interestingly, meprin β deficiency led to decreased 
inflammatory cell number in the pouch lavage in comparison to the control group, demonstrating a 
crucial role for meprin β in cell extravasation (Figure 24B).  
Besides inflammatory cells, CD99 could also be found on cancer cells. High CD99 expression is a 
hallmark of certain cancer cells like Ewings sarcoma (Ambros et al., 1991; Fellinger et al., 1991). 
Additionally, meprin β expression could be found in primary and metastatic sites of pancreatic 
neuroendocrine tumors and might promote metastasis of cancer cells through cleavage of CD99 (Carr 
et al., 2013; Maitra et al., 2003). Two databank annotated CD99 mutations of lung squamous cell 
carcinoma (p.D92H) and lung adenocarcinoma (p.D92Y) were analyzed with regard to meprin β 
cleavage and cell migration. Of note, the mutated Asp92 is located at the P1’ position within the 
meprin β cleavage site, leading to generation of the CTF II. Loss of CD99 cleavage by meprin β might 
alter cell migration ability and therefore be disadvantageous for the tumor cell. The mutated CD99 
variants were co-transfected with meprin β in HeLa cells. Western blot analysis revealed cleavage of 
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CD99 by meprin β and production of the CTF II in all CD99 variants (Figure 24C). Subsequent mass 
spectrometry analysis identified a shift of the cleavage site to Asp94, two amino acids C-terminal of 
the mutated site at Asp92. Additionally, the D92H variant of CD99 showed significantly increased cell 
migratory potential compared to wildtype form. In order to investigate downstream signaling of CD99 
shedding by meprin β, phosphorylation of Src kinase was analyzed via Western blot. The full-length 
isoform of CD99 was described to inhibit Src phosphorylation and thereby decrease anchorage-
independent growth, migration and metastasis of tumor cells (Scotlandi et al., 2007). Interestingly, 
transfection of each CD99 variant did not alter Src phosphorylation in osteosarcoma U2-OS cells 
(Figure 24D). However, treatment of these cells with recombinant active meprin β increased pSrc 
levels independently from CD99. 
 
Figure 24: Meprin β mediates inflammatory cell migration in vivo and enhances Src phosphorylation. 
(A) Air pouch model for induction of acute inflammation in meprin β deficient mice and wildtype littermates. Six days after 
subcutaneous injection of sterile air, administration of carrageenan into the dorsal air pouch induces immune cell infiltration. 
Pouch lavage was isolated 24 h later. (B) Total cells in pouch lavage were counted and normalized to wildtype. Cell 
infiltration was significantly reduced in meprin β deficient mice. (C) Cancer-associated mutations in the meprin β cleavage 
site of CD99 do not alter generation of CTF II. (D) Treatment of U2-OS cells with recombinant meprin β enhances 
phosphorylation of Src kinase. Adapted from (Bedau et al., 2017b), appendix 2. 
Overall, extravasation of inflammatory cells was shown to be dependent on meprin β presence in an in 
vivo acute inflammation model. Moreover, cancer-associated mutated variants of CD99 could still be 
cleaved by meprin β by a shifted cleavage site and D92H variant exhibited increased migratory 
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potential. Phosphorylation of Src kinase was not altered after over-expression of CD99 in cell culture, 
as reported before (Scotlandi et al., 2007). Interestingly, presence of meprin β increased pSrc, thereby 
potentially promoting pro-tumorigenic activity of malignant cells (this was published (Bedau et al., 
2017b) and is attached as appendix 2). 
 
3.5 Expression and localization of meprins can change in certain pathological conditions and 
alters cell migration and gene expression  
The localization of proteins is strictly regulated by their signal peptide or localization sequences within 
the amino acid sequence, which guides the translated protein to its place of destination. Proteins with a 
transmembrane domain mainly remain in membrane compartments, while soluble proteins are 
secreted, cytosolic or stay in cellular organelles. Cellular polarization and sorting of proteins to either 
apical or basolateral sites of a cell is of high scientific interest because missorting could promote or 
arise from developing pathologies. Meprin proteases are mainly found at apical sites of cells, e.g. in 
the luminal part of kidney or intestinal epithelial cells. However, missorting of meprins to the 
basolateral site was observed during acute renal ischemia reperfusion (Trachtman et al., 1995), 
glomerulonephritis (Oneda et al., 2008) and in tumor stroma (Lottaz et al., 1999), demonstrating a 
switch from physiological to pathological activity of meprins. Due to its inserted domain, meprin α is 
shed by furin on the secretory pathway and secreted into the extracellular space (Marchand et al., 
1995). Interestingly, meprin α could also be found on cell surfaces of epithelial cells, indicating 
possible interactions of soluble meprin α with membrane resident proteins that could alter function of 
the protease. 
Apical localization of meprin α was observed in lung epithelial cells and pulmonary arteries of donors 
and idiopathic pulmonary arterial hypertension (IPAH) patients. However, increasing amount of 
circulating soluble meprin α was measured in the plasma of IPAH patients (Figure 25A). In in vitro 
binding experiments, recombinant meprin α was able to bind to isolated donor human pulmonary 
artery endothelial cells (hPAEC) in a concentration dependent manner, which could be reduced by 
treatment with heparinase I (Figure 25B) or was impaired in CHO cells deficient for 
glycosaminoglycan (GAG) or heparan sulphate. Moreover, confocal microscopy of lung sections 
confirmed a co-localization of meprin α and heparan sulphate on the extracellular-luminal site (Figure 
25C) and less expression levels of heparan sulphate could be observed in pPAECs of IPAH patients 
that showed reduced absorption of recombinant meprin α (Figure 25D). In order to unravel the role of 
membrane localized meprin α in epithelial cells, epithelial barrier function of hPAECs was 
investigated in presence or absence of meprin α. hPAEC monolayer was activated with LPS and 
treated with active meprin α. After subsequent addition of isolated neutrophils from the blood of 
healthy donors, changes in electrical impedance were measured. While LPS treatment decreased 
epithelial barrier function and led to invasion of neutrophils, meprin α significantly impaired migration 
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of neutrophils (Figure 25E). As a proof of concept, hPAECs were pre-treated with heparinases to 
remove heparan sulphate and to prevent meprin α binding to the cell surface. Indeed, neutrophil 
migration was slightly abolished in a short time interval, demonstrating a role for membrane bound 
meprin α in immune cell invasion through endothelial barriers (this was published in (Biasin et al., 
2018) and is attached as appendix 3). 
 
Figure 25: Meprin α binds to heparan sulphate in pulmonary artery epithelial cells and mediates immune 
cell migration. 
(A) Significantly elevated levels of soluble meprin α were measured in plasma of IPAH patients. (B) Recombinant meprin α 
was able to bind to hPAECs in a dose dependent manner (n = 6, data are shown as mean ± SD). (C) Immunofluorescence 
staining for meprin α (red) and heparan sulphate (green) of a donor lung section revealed co-localization of both proteins. (D) 
Significant binding of 100 nM recombinant meprin α to donor and not IPAH hPAECs (n = 3, data are shown as mean ± SD). 
(E) Addition of meprin α to LPS activated hPAECs reduced neutrophil invasion by increased electrical resistance compared 
to vehicle. Pre-treatment of hPAECs prevented meprin α binding and promoted neutrophil invasion (n = 3). Adapted from 
(Biasin et al., 2018), appendix 3. 
Besides heparan sulphate, meprin α can also bind to meprin β. Shortly after discovery of meprins, it 
became evident that meprin α and meprin β can form a heterodimer in mice and rat when co-expressed 
in the same tissue (Johnson and Hersh, 1992; Marchand et al., 1995). This is important to investigate, 
since formation of a meprin enzyme complex might have impact on meprin β shedding and activation 
on the cell surface. For instance, membrane bound meprin α might be able to be activated and could 
cleave substrates on the cell surface, which are not accessible in its soluble form. 
In order to elucidate the interaction of human meprin α and meprin β, both proteases were expressed in 
HeLa cells. An additional meprin α fragment of 100 kDa was observed in lysates of co-transfected 
cells (Figure 26A, marked with an asterisk) and the mature, fully glycosylated meprin β fragment 
showed reduced molecular weight in presence of meprin α. Immunoprecipitation of one of the 
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proteases from cell lysates confirmed a direct interaction of human meprins as reported for the rodent 
isoforms. By mutagenesis of the intermolecular disulfide-bridge forming cysteine C305 (meprin β) 
and C308 (meprin α) to a serine in the MAM domain of both proteases, dimerization of meprins could 
be prevented. Based on the solved crystal structure of human meprin β homodimer (PDB code 4gwm) 
(Arolas et al., 2012), a homology model of the meprin enzyme complex was generated (Figure 26B). 
Of note, all interaction sites of the meprin β homodimer were also found in the heterodimer. 
Furthermore, an additional salt-bridge could be formed between R578 (meprin α) and E270 (meprin β) 
and a hydrogen bond between D201 (meprin α) and S257 (meprin β), indicating potentially increased 
stability of the enzyme complex compared to the homodimers. Next, localization and assembly of the 
meprin enzyme complex were further analyzed. Biotinylation experiments revealed an interaction on 
the cell surface that tethered the soluble 100 kDa meprin α fragment to the plasma membrane. 
However, connection of the proteases occurred already in the ER, which could be observed by 
treatment of cells with Brefeldin A, a potent inhibitor for the transport from the ER to the Golgi 
apparatus. To shed light on the previously observed shift of the mature meprin β within the enzyme 
complex, protein deglycosylation was performed. Removement of attached sugar residues revealed 
that the shift was a product of altered glycosylation and not of proteolysis at the N- or C-terminus of 
meprin β. Interestingly, the shift was also present in co-transfection with the cysteine variants and 
might not result from enzyme complex formation (Figure 26A). In order to investigate if glycosylation 
itself had an impact on heterodimer formation, transfected HeLa cells were treated with glycosylation 
inhibitors that prevent maturation of sugar trees in the ER (Kifunensine) and in the Golgi apparatus 
(Swainsonine). Immunoprecipitation of meprins showed differentially glycosylated proteases that still 
formed a heterodimer. Human meprin β possesses 8 potential N-linked and 4 O-linked glycosylation 
sites. Two N-linked glycosylation sites were mutated by disruption of the Asn-X-Ser/Thr consensus 
sequence at position N370, T372, N547 and T549. Of note, loss of the attached sugar residue at 
position N547 resulted in inappropriate folding of the enzyme and therefore had crucial function for 
the stability of meprin β (Figure 26C). In contrast, loss of the sugar residue at position N370 had no 
effect on meprin β maturation. However, molecular shifts appeared both in the ER- and maturated 
form. Next, the functional properties of each meprin within the heteromeric complex were analyzed. 
Both meprin proteases can be activated by tryptic proteases on the cell surface or in the extracellular 
space by cleaving off the inhibitory pro-peptide (Grünberg et al., 1993; Johnson and Bond, 1997; 
Ohler et al., 2010). It was questionable whether the heterodimer might have an impact on the 
activation of each monomer. Therefore, meprin activity was measured on cell surfaces and in cell 
supernatants using specific fluorogenic peptides for meprin α or meprin β. While activation of meprin 
β by the bacterial protease RgpB on the cell surface was not altered in presence of meprin α, 
membrane bound meprin α itself could also be activated by RgpB on the plasma membrane which 
could lead to cleavage of so far unknown membrane bound substrates (Figure 26D). However, 
cleavage of the amyloid precursor protein (APP) and the adhesion molecule CD99, both well 
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described substrates of meprin β, did not occur by membrane bound meprin α. Although both meprins 
have a common preference for negatively charged amino acids around the scissile bond (Becker-Pauly 
et al., 2011), substrates might differ between both proteases within the enzyme complex. Noteworthy, 
both meprin α and meprin β activities increased within the heterodimer in the cell supernatant while 
neither expression nor shedding of the complex was increased (Figure 26E). Finally, the biological 
relevance of the meprin heterodimer should be elucidated in vivo. The absence of meprin α on the 
apical site of intestinal epithelial cells could be observed in meprin β deficient mice (Figure 26F). 
Additionally, intestine lysates showed the glycosylation shift of meprin β and an altered fragment 
pattern of meprin α, in accordance with the previous human in vitro data. In human and murine gut, 
absence of meprin α was associated with a higher risk for inflammatory bowel disease (IBD) 
progression (Banerjee et al., 2009; Häsler et al., 2017). Therefore, the potential role of altered meprin 
α localization on gene regulation with regard to IBD should be investigated. Comparison of 
transcriptome analyses of wildtype, meprin α- and meprin β knock-out mice revealed changes in 
regulation of gene subsets when meprin α was located on cell membranes or in the intestinal lumen or 
when meprin α was totally absent. 
In summary, the human meprins form disulfide-linked heterodimers when co-expressed, which leads 
to a plasma membrane localization of meprin α and changes in posttranslational modifications (Figure 
26G). Furthermore, meprin α can be activated on the cell surface but was not able to cleave known 
meprin β substrates. However, the meprin enzyme complex exhibited enhanced stability and increased 
activity of each meprin monomer. Additionally, transcriptome analyses revealed changes in gene 
subsets depending on localization of meprin α, demonstrating the physiological relevance of the 
meprin enzyme complex (this was published in (Peters et al., in press) and is attached as appendix 4). 
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Figure 26: Meprin α and meprin β form an enzyme complex that tethers meprin α to the cell membrane 
and alters gene expression. 
(A) Co-immunoprecipitation of transfected meprin α with meprin β or meprin β C305S in HeLa cells revealed disulfide 
linkage and altered posttranslational modifications of both proteases. (B) Homology model of the meprin enzyme complex 
with interacting amino acid residues. The approximate position of the intermolecular disulfide bond between C305 and C308 
of the heterodimer is highlighted via a yellow line. (C) Mutation of glycosylation site N547 in meprin β led to inappropriate 
folding and ER retention of the protease. (D) Membrane bound meprin α could be activated by RgpB within the meprin 
enzyme complex on the cell surface (n = 3). (E) Shed meprin β showed significantly increased activity within the meprin 
enzyme complex in cell supernatants (n = 3). (F) Co-immunofluorescence staining for meprin α (green) and meprin β (red) in 
small intestine sections of wildtype, meprin β knock-out and meprin double knock-out mice. Surface staining of meprin α in 
endothelial cells was not obtained in meprin β deficient mice. (G) Meprin β is shed by ADAM10/17 on the plasma membrane 
in single transfection and in the meprin enzyme complex. Meprin α is processed by furin on the secretory pathway and 
secreted into the extracellular space. Tethered to meprin β in the heterodimer, meprin α requires shedding of meprin β. 
Adapted from (Peters et al., in press) appendix 4. 
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4. Discussion 
4.1 Expression and localization of meprins regulate ECM turnover and cell migration 
Since discovery of meprin metalloproteases in different species, ongoing identification of substrates in 
vitro and in vivo sheds light on their role within the proteolytic web in various tissues. A well suitable 
model for understanding the biological function of a protein is the generation of knock-out mice. For 
example, if a target protein is involved in embryonic development, its absence may cause defects in 
organogenesis or could result in prenatal lethality. In case of meprin α and meprin β, knock-out mice 
are viable and show no obvious phenotype compared to wildtype mice (Banerjee et al., 2009; Norman 
et al., 2003). However, dermal thickness in skin is reduced and showed less tensile strength, less 
collagen deposition and an Ehlers-Danlos syndrome-like phenotype (Broder et al., 2013). A more 
important role for meprins emerged through pathology-associated mouse models. DSS-treated meprin 
α knock-out mice were more susceptible to inflammation and intestinal injury compared to littermates 
(Banerjee et al., 2009). In line with this, reduced mRNA expression of meprin α was observed in 
inflamed mucosa of patients suffering from Crohn’s disease (CD) or ulcerative colitis (UC), 
highlighting a possible protective role of meprin α for the onset of disease (Banerjee et al., 2009; 
Häsler et al., 2017). An anti-inflammatory function of meprin α was further shown in human 
pulmonary artery endothelial cells (hPAEC), where binding of meprin α to heparan sulphate prevented 
infiltration of inflammatory cells (Biasin et al., 2018). However, in contrast to the protective role in 
IBD, meprin α impaired the integrity of the endothelial monolayer of hPAECs, which could also 
coincide for meprin α being located at the plasma membrane in an enzyme complex with meprin β. 
Since meprin β can be shed by ADAM proteases from the cell surface (Herzog et al., 2014; Wichert et 
al., 2017), the release of meprin α from endothelial cells in an enzyme complex would be a regulated 
process by limited proteolysis that could restore barrier integrity in IBD. Interestingly, meprin β 
knock-out mice were rather protected from injury after DSS-induced colitis, indicating that expression 
of meprin α might prevent IBD progression, when the enzyme is not tethered to the epithelium 
(Banerjee et al., 2011). Both, the anti-inflammatory function and the impairment of the endothelial 
layer by meprin α, point towards a tightly regulated mechanism in which substrate availability, 
different cell types and localization of the enzyme have a crucial impact on the enzymes function. This 
could be further strengthened by another contrary observation, which was made in a scratch wound 
healing assay in the present study, where inhibition of endogenous meprin α by actinonin as well as 
addition of recombinant active meprin α decelerated cell migration.  
Migration and metastasis of cancer cells require ECM remodeling and cleavage of adhesion molecules 
by proteases. Actinonin treatment of human breast carcinoma cells and silencing of meprin α in liver 
cancer cells HepG2 and Huh7 decreased migration and invasiveness in vitro, while over-expression or 
recombinant active meprin α promoted migration (Breig et al., 2017; Matters et al., 2005). In contrast 
to epithelial expressed meprin α, observations in human colorectal adenocarcinoma cells (CaCo-2) 
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revealed secretion of meprin α also to the basolateral site, thereby leading to an accumulation in tumor 
stroma for ECM remodeling (Minder et al., 2012). Mechanistically, cleavage of EGFR by meprin α 
and subsequent ERK1/2/MAPK phosphorylation could result in the accelerated migration, while 
meprin α itself could be activated by Reptin, a protein that contributes to tumor malignancy (Breig et 
al., 2017; Ren et al., 2013). Besides meprin α, meprin β expression was also identified in cancer cell 
lines like HeLa cells or HT29 colon adenocarcinoma cells, where meprin β could promote cancer cell 
migration through cleavage of adhesion molecules (Dietrich et al., 1996). The adhesion molecule 
CD99 is a hallmark of Ewing Sarcoma and was identified as potential meprin β substrate in a 
proteomics approach (Ambros et al., 1991; Fellinger et al., 1991; Jefferson et al., 2013). Further 
characterization of the meprin β cleavage of CD99 revealed enhanced transendothelial migration of 
Lewis lung carcinoma cells (Bedau et al., 2017a). Moreover, cancer-associated mutations within the 
meprin β cleavage site in CD99 did not prevent but rather increased cell migration (Bedau et al., 
2017b). Interestingly, meprin β over-expression in HeLa cells was shown to increase phosphorylation 
of Src kinase, which could promote anchorage-independent growth, survival and spreading of cancer 
cells. Potential inductors of meprin β expression are retinoic acid or phorbol myristal actetate, that 
further activate the transcription factor complex AP-1 (Dietrich et al., 1996; Matters and Bond, 1999; 
Sharma and Richards, 2000). Interestingly, transcribed meprin β mRNA in cancer cells differs from 
the mRNA expressed in kidney and intestine by alternative splicing and altered promoter binding 
usage (Dietrich et al., 1996; Jiang et al., 2000; Matters and Bond, 1999). Indeed, AP-1 and PEA3 
binding elements were identified upstream of the meprin β gene, that could be used besides the tissue 
specific promoter sites for kidney and intestinal epithelial cells. The alternative splicing in murine 
cancer cells lead to an elongated meprin β’ with differences in signal peptide and pro-peptide 
compared to meprin β in kidney (Jiang et al., 2000). In contrast, human meprin β’ mRNA differs 
solely in the 5’ untranslated region. This indicates variances in stability or expression rather on RNA 
level than on protein level, which might be beneficial for cancer cells. The induction of meprin β’ by 
the AP-1 transcription factor complex could be further strengthened by the Fra2 transgenic mouse 
model (Eferl et al., 2008). As part of AP-1, Fra2 over-expression in mice led to fibrosis of the lung and 
an early death of the mice. Here, meprin β was identified as most highly upregulated gene in these 
lungs promoting ECM deposition and fibrosis (Biasin et al., 2014). Indeed, transcription of meprin β’ 
mRNA was observed in fibrotic skin of Fra2 tg mice, confirming the pathology-associated regulation 
of meprin β’ by AP-1, as described in cancer cells. Biasin and colleagues further identified TGFβ as 
another possible activator of AP-1 and meprin β in pulmonary lung arteries (Biasin et al., 2014). The 
growth factor TGFβ influences cell migration, differentiation and tissue regeneration and plays a 
major role in wound healing processes (Frank et al., 1996; Massagué, 2012). Since meprin knock-out 
mice show reduced collagen deposition in the dermis, where meprins maturate proteins of the ECM 
(Broder et al., 2013; Kronenberg et al., 2010), their role in wound healing should be elucidated. 
Interestingly, loss of the meprin related astacin proteases BMP-1 and Tll1 resulted in delayed wound 
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healing and markedly thinned and fragile skin (Muir et al., 2016). In the present study, meprin double 
knock-out mice revealed reduced re-epithelialization by migrating keratinocytes. Further, an in vitro 
assay regarding keratinocyte migration showed decreased migration of actinonin-treated HaCaT 
keratinocytes on the one hand and slightly increased wound healing of isolated meprin double knock-
out keratinocytes on the other hand. These opposing results might arise due to the case that the HaCaT 
cell line consists of immortal cells differing in gene expression to primary keratinocytes. Moreover, 
platelets and inflammatory cells also contribute to wound healing in various stages and supply diverse 
cytokines like TGFβ and PDGF,  growth- and angiogenic factors, which are missing in cell culture 
(Martin and Leibovich, 2005). Previous studies further reported expression of meprins on CD45+ 
leukocytes in the lamina propria of human inflamed bowel and mesenteric lymph node where loss of 
meprin β by gene knock-out decreased the ability of leukocytes to migrate through matrigel (Crisman 
et al., 2004; Lottaz et al., 1999). Comparable to this, less infiltration of inflammatory cells was 
observed in an air pouch acute inflammation model with meprin β deficient mice and wildtype 
littermates (Bedau et al., 2017b, 2017a). Here, cell migration probably functions via cleavage of CD99 
by meprin β or reduced ECM remodeling. Therefore, analysis of inflammatory cells in wounds of 
meprin deficient mice should be performed in order to elucidate the role of meprins for inflammatory 
cell infiltration in wound healing. 
Another possibility for the unaltered wound healing in meprin single knock-out mice could be 
compensatory expression of other enzymes replacing meprin activity. Both meprin α and meprin β 
have a preference for acidic amino acid residues and an overlapping substrate spectrum (Becker-Pauly 
et al., 2011; Jefferson et al., 2013). Therefore, loss of one meprin might be compensated by the other 
meprin enzyme. In normal murine skin homeostasis, no increased expression of the remaining meprin 
or other astacin family members was observed in knock-out mice. However, a compensatory effect 
during wound healing remains to be elucidated. Obviously, loss of both meprins reduced re-
epithelialization in wound healing studies, while presence of only one meprin was sufficient for 
normal re-epithelialization. The meprin related proteases BMP-1 and Tll1 were also found to be 
expressed in murine skin, likewise preferring acidic amino acid residues and cleaving similar 
substrates like meprins (Becker-Pauly et al., 2011; Hopkins et al., 2007). Interestingly, loss of both 
BMP-1 and Tll1 (BTPs) in skin of conditional knock-out mice reduced wound closure, wound 
thickness and re-epithelialization, indicating that meprins and BTPs have diverse functions in wound 
healing like different substrates or are expressed in other cells and/or other stages of the healing 
process (Muir et al., 2016).  
4.2 The role of meprin β in the onset of skin diseases 
Since identification of meprin expression in skin (Becker-Pauly et al., 2007), research has focused on 
maturation of potential substrates that play a role in ECM constitution. First, procollagen III was 
shown to be maturated both at the N- and the C-terminus by meprin α and meprin β (Kronenberg et al., 
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2010). To that time, collagen maturation was known to be performed by different proteases cleaving 
only the C-terminus (tolloid proteases and BMP-1) or the N-terminus (ADAMTS-2, 3 and 14) leading 
to collagen fibril formation (Hopkins et al., 2007). Consistent with the other astacin-like proteinase 
family members BMP-1 and Tll1, equal processing of procollagen by meprins could be observed with 
the exception that meprins were not dependent on the procollagen C-proteinase enhancer-1 (PCPE-1) 
(Kronenberg et al., 2010). A following study focused on meprin cleavage of another fibrillary collagen 
in skin, collagen I (Broder et al., 2013). As shown for procollagen III, N- and C-terminal processing of 
procollagen I was performed by meprins in vivo and in vitro, leading to spontaneous fibril formation 
of recombinant procollagen I. Furthermore, less tightly packed collagen fibrils were observed in 
meprin knock-out mice reducing overall tensile strength of the skin. In addition to the identification of 
meprins in skin, their expression in different skin diseases and keratinization disorders was studied. An 
altered distribution of meprins was observed within hyperproliferation of the epidermis in Netherton 
syndrome and psoriasis vulgaris (Becker-Pauly et al., 2007). Meprin α was not only observed in the 
basal layer but also in the uppermost layers of the epidermis, while meprin β showed also signals in 
the cornified layer. Moreover, in keloid dermis, meprins showed increased expression, most likely 
supporting the enhanced deposition of ECM (Kronenberg et al., 2010). Altogether, these observations 
emphasized meprins as potential target in the onset of skin disorders like fibrosis or psoriasis. 
Mouse models can be used for the study and understanding of disease developments like fibrosis in an 
organism since in vitro models are limited in time and tissue/cell interplay. Therefore, several genetic 
mouse models have been established, for example targeting the TGFβ activation pathway or the 
connective tissue protein fibrillin (Smith and Chan, 2010). Also, chemical agents such as bleomycin 
can be used to induce dermal fibrosis, accumulation of myofibroblasts and ECM deposition via TGFβ 
activation (Yamamoto et al., 1999). Bleomycin-treatment of meprin knock-out mice was performed in 
order to elucidate the role of meprins in developing lung fibrosis (Biasin et al., 2017). Meprin β 
deficient mice had decreased collagen deposition and tissue density, again proving its role in ECM 
development. However, no changes in lung function or infiltration of immune cells could be observed. 
Furthermore, meprin double deficient mice did not show alterations compared to wildtype mice, 
indicating possible compensation by other collagen maturating enzymes. The role of meprin β in lung 
fibrosis was also highlighted in the genetic model of Fra2 over-expressing mice. Transgenic mice 
developed lung fibrosis and pulmonary hypertension that led to an early death (Eferl et al., 2008). 
Here, Fra2 was identified as transcription factor of meprin β, that was the most highly upregulated 
gene in the fibrotic lungs and might contribute to the excess collagen deposition (Biasin et al., 2014). 
Not only the lungs were affected by fibrosis, also the skin showed thickening of the dermis and 
increased collagen densities from week 12 to 16 (Maurer et al., 2009; Reich et al., 2010). A thickening 
of dermis and epidermis could be confirmed in this study, with additional increase in fibrosis marker 
genes ACTA2, Col1a2 and TGFβ1. Interestingly, meprin β was also highly upregulated with high 
variation between the individual mice. In this mouse model, the role of meprin β in the developing 
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lung or skin fibrosis needs further investigation. On the one hand, meprin β knock-out mice could be 
crossed to Fra2 transgenic mice to exclude influence of meprin β in any cell type and tissue. However, 
the meprin β gene and the introduced Fra2 transgene are both located close together on chromosome 
18, complicating breeding or combination of both alleles on one chromosome by homologous 
recombination. To overcome this problem, the Mep1b gene could be disrupted in Fra2 transgenic mice 
using the novel technique CRISPR/Cas9. Here, possible off-target effects have to be considered and 
excluded (Zhang et al., 2015). On the other hand, meprin β activity could be blocked by treatment of 
Fra2 mice with a specific meprin β inhibitor. This method requires some pharmacological aspects like 
toxicity and stability of the inhibitor. Furthermore, the amount and time interval of the applied 
inhibitor as well as its specificity for meprin β have to be tested. These approaches could prove the 
role of meprin β in developing fibrosis. However, the Fra2 mouse model is limited for studying 
ongoing skin fibrosis as mice die from lung failure shortly after onset of disease. Nevertheless, it is a 
valuable model to study systemic fibrotic disease and relevant participating proteins like meprin β. 
A more comprehensive mouse model for studying the impact of meprin β contribution to skin diseases 
is the direct over-expression of the enzyme in specific cells. Therefore, a Cre recombinase inducible 
meprin β over-expressing mouse model was generated. To target the major collagen expressing cells 
in skin, meprin β over-expressing mice were crossed to Col1a2-Cre mice, leading to meprin β 
expression in fibroblasts that transcribe the α2 chain of type I collagen (Zheng et al., 2002). 12 weeks 
old mice did not develop an obvious phenotype after tamoxifen induction and type I collagen 
maturation and deposition in the dermis appeared unaltered compared to control littermates. Since 
Fra2 tg mice start to develop fibrotic skin from week 12, meprin β over-expression in fibroblasts 
should be further investigated at higher age. Although meprin β expression was observed in the 
dermis, it is likely that no endogenous activators of meprin β were present in dermal fibroblasts. 
Reported skin expressed meprin β activators are kallikrein-related peptidases KLK4, 5 and 8 (Ohler et 
al., 2010). However, these enzymes are only expressed in the upper parts of the epidermis and thought 
to be essential for desquamation and skin barrier function (Brattsand and Egelrud, 1999; Komatsu et 
al., 2003, 2005). The other meprin β activator trypsin was identified in basal keratinocytes, vascular 
endothelial cells and macrophages (Becker et al., 2003; Koshikawa et al., 1997, 1998). Interestingly, 
aberrant trypsin expression was linked to pathological processes like inflammation and tumor 
invasion. The only known membrane bound meprin β activator matriptase-2 was not identified to be 
expressed in skin so far (Jäckle et al., 2015). It might be possible that fibroblasts express not yet 
identified meprin β activators or that known activators are produced by infiltrating cells in skin 
diseases linked to inflammation. Furthermore, increased meprin β expression must not necessarily lead 
to increased expression of ECM components that require maturation by meprin β. In skin of meprin β 
deficient mice, no change in expression of fibrosis related genes ACTA2, TGFb1 and Col1a2 has been 
observed in a fibrosis PCR array (Broder et al., 2013). This is in line with protein level of full length 
and maturated collagen I, which appeared unaltered in the over-expressing mice. Also no increased α-
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SMA could be observed, which is a well-established marker for myofibroblasts. During tissue injury, 
fibroblasts differentiate to myofibroblasts that are contractile and deposit ECM like collagens for 
tissue repair. Persistence of myofibroblasts after wound closure is thought to be significant for 
propagation of fibrosis (Hinz et al., 2007). Little to no co-localization of meprin β and α-SMA was 
observed in immunofluorescence staining in skin, indicating meprin β expression on quiescent skin 
fibroblasts. Therefore, over-expression of meprin β in dermal fibroblasts does not promote 
development of skin fibrosis in 12 week old Col1a2-Cre MB-KI mice. Probably, other fibrosis 
stimulating factors or cell types are needed to promote onset of skin fibrosis and meprin β expression 
might occur from a downstream mechanism. 
Other skin diseases that involve altered meprin expression like psoriasis vulgaris and Netherton 
syndrome target the epidermis (Becker-Pauly et al., 2007). Hence, induction of meprin β over-
expression in the epidermis was performed using tamoxifen inducible Cre recombinase via cytokeratin 
5 promoter in basal keratinocytes. Interestingly, affected mice developed a reticulate pigmentation 
phenotype during tamoxifen treatment that was present in ears, tails and dorsal skin. Furthermore, 
mice suffered from hair loss and showed thickening of the epidermis. A comparison of the symptoms 
with known human diseases and syndromes pointed towards phenotypes as described for 
Dermatopathia Pigmentosa Reticularis (DPR) or Epidermolysis bullosa simplex with mottled 
pigmentation and noncicatricial alopecia (MP-EBS) (Belligni et al., 2011; Nagai et al., 2016). In both 
rare syndromes, patients were described suffering from reticulate pigmentation spread over their body 
and non-scarring hair loss. The trigger for the developing syndrome was identified by sequencing 
analyses of patients that revealed dominant mutations in KRT5 or KRT14, which lead to a loss of 
function of cytokeratins to form heterodimeric fibrils in keratinocytes (Lee et al., 2012). Since these 
mutations are not present in the meprin β over-expressing mouse model, a more complex molecular 
mechanism should be considered that promotes these phenotype. Decreased expression of one of the 
cytokeratins was supposed, which could prevent proper fibril formation. Interestingly, even increased 
transcription of cytokeratin 14 and 5 could be observed in the meprin β over-expressing mouse model. 
For cytokeratin 14, a 20 kDa C-terminal fragment occurred predominantly in meprin β over-
expressing skin lysates in Western blot analyses. This fragment might correlate to the overall 
increased cytokeratin 14 level or be indicative of fibril cleavage and depletion. Nevertheless, direct 
cleavage of intracellular cytokeratin 14 by meprin β appeared unlikely because the enzyme is located 
on the outer plasma membrane. Keratin fibrils are connected to the plasma membrane via protein 
components of the desmosomes and hemidesmosomes that are located within the outer membrane 
(Fuchs and Raghavan, 2002). Loss of this connection by meprin β cleavage would disrupt the 
cytoskeleton of keratinocytes and probably mimic loss of proper keratin fibril formation and induce 
cell stress. Of note, desmogleins were described as candidate substrates for meprin β in an in vitro 
proteomics approach (Jefferson et al., 2013). Therefore, expression of desmosomal molecules 
desmoglein 1 and 3 was investigated in meprin β over-expressing mice. Interestingly, full length 
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desmoglein 1 signals were only obtained in control mice skin in Western blot analysis but expression 
was unchanged on mRNA level. For desmoglein 3, no full length form could be observed but a 
cleavage fragment of 20 kDa appeared mainly in meprin β over-expressing mice while mRNA levels 
were significantly increased. Cleavage of desmogleins 1 and 3 by meprin β could disrupt adhesion 
capability of keratinocytes and lead to the hair loss phenotype as described for desmoglein 3 -/- mice 
(Koch et al., 1997). Hence, desmoglein 1 and 3 might represent novel in vivo substrates for meprin β 
or they are cleaved by a downstream protease. Kallikreins were shown to interact with meprin β and 
cleave corneodesmosomal proteins leading to desquamation of keratinocytes (Caubet et al., 2004; 
Ohler et al., 2010). However, desmoglein 1 was only cleaved by KLK5, a meprin β activator, and not 
by KLK7, which can be activated by meprin β. Furthermore, other adhesion molecules were 
considered as potential meprin β substrates in the epidermis. E-cadherin mediates intercellular 
adhesion junctions of keratinocytes and hair follicles and loss of E-cadherin promotes hair loss and 
alters differentiation of epidermal keratinocytes (Young et al., 2003). Moreover, E-cadherin was 
described to be cleaved by meprin β, thereby generating a 100 kDa fragment (Huguenin et al., 2008). 
Interestingly, cleavage fragments were obtained in all genotypes but showed increased signals in 
meprin β over-expressing mice. For β1 integrin, on the other hand, whose loss in mice leads also to 
hair loss and hyperthickening of the epidermis (Brakebusch et al., 2000), less cleavage fragments and 
stabilization of the full length protein was observed in presence of meprin β. Summarizing, there are 
hints that point out cleavage of adhesion molecules by meprin β in the epidermis. Loss of adhesion 
could promote early desquamation of keratinocytes, mechanical cell stress and induce 
hyperproliferation of keratinocytes in order to compensate tissue fragility (Kottke et al., 2006). 
However, identification of particular epidermis related substrates for meprin β remains elusive and 
might resolved by an overall proteomics screen using mass spectrometry.  
Chronic skin inflammation and hyperproliferation are also hallmarks of psoriasis. Expression of 
meprin β was widely associated with inflammation and the release of pro-inflammatory cytokines like 
IL6, IL1β and IL18 by macrophages (Li et al., 2014). Interestingly, keratinocytes itself are also able to 
express interleukins that act in an autocrine or paracrine fashion to themselves or other skin cells 
(Baliwag et al., 2015). Therefore, expression of pro-inflammatory cytokines in skin of meprin β over-
expressing mice was investigated. Indeed, upregulation of IL6, Il1β and IL18 was present in 
comparison to control mice as well as higher expression of the Langerhans cell marker CD207 and 
macrophage marker Adgre1 that could indicate an inflammatory condition and subsequent 
pigmentation of the skin. The unusual dermal pigmentation, which was seen in the mouse tails, points 
towards a pigmentary incontinence, a process that follows inflammation and cell damage and that was 
described in DPR patients (Belligni et al., 2011; Masu and Seiji, 1983). In normal skin homeostasis, 
melanin is transported as melanosomes from melanocytes to keratinocytes in order to protect the 
nucleus from UV radiation and DNA damage (Yamaguchi et al., 2007). Upon cell damage, free 
melanosomes are taken up by dermal macrophages, also called melanophages, that persist within the 
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dermis (Masu and Seiji, 1983). An increased amount of melanocytes was not observed in meprin β 
over-expressing mice, but overall melanin production showed an increase which can be also observed 
during inflammatory processes. Upon inflammatory cytokine secretion or UV radiation, keratinocytes 
produce prostaglandins, e.g. α-MSH (α-melanocyte-stimulating hormone), that stimulate the melanin 
production (Brenner and Hearing, 2008). Excessive melanosomes and pigment are then taken up by 
melanophages and stored within in the dermis, a process that is also used for inlaying tattoo pigment 
(Baranska et al., 2018; Collin, 2018). Therefore, the pigmentation phenotype could be a secondary 
effect of meprin β over-expression, which might resulted from skin inflammation and cellular stress by 
loss of adhesion of keratinocytes within the cellular network. Interestingly, upon UV radiation and 
tanning of human skin, total amount of melanocytes was shown to remain unchanged as seen in the 
meprin β over-expressing mouse model (Tadokoro et al., 2005). Furthermore, Tadokoro and 
colleagues reported distribution of melanin to the upper layers of the epidermis as a long term result 
after UV radiation. This distribution to the upper part was also observed in meprin β expressing 
regions in ear and dorsal skin. Therefore, over-expression of meprin β in the epidermis might activate 
similar mechanisms as UV damage that also result in thickening of epidermis and inflammation 
(D’Orazio et al., 2013). However, additional research is needed for understanding the exact underlying 
mechanism. 
 
Figure 27: Phenotypic changes of epidermis by meprin β over-expression. 
Meprin β over-expression in basal keratinocytes might lead to cleavage of adhesion molecules in desmosomes and 
hemidesmosomes, which induces cellular stress. Mechanical problems of the epidermis are compensated by 
hyperproliferation of keratinocytes. In order to protect affected keratinocytes, α-MSH (α-melanocyte-stimulating hormone) 
secretion leads to melanin production in melanocytes, which is transported to keratinocytes. Excessive melanin in the dermis 
is taken up by melanophages and stored (pigmentary incontinence). Furthermore, secretion of pro-inflammatory cytokines 
induces inflammation, resulting in immune cell infiltration and a psoriasis like phenotype. 
Conclusively, over-expressing meprin β in the epidermis might result in induction of cell stress, 
inflammation and development of a psoriasis like phenotype. Hence, increased meprin β expression in 
psoriatic skin diseases with pigmentation could be considered as hallmark for development and 
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progression of disease. Establishment of the meprin β over-expressing mouse model could also be 
used for generation and investigation of other inflammatory disease models where meprin β activity 
could play a role. As proof of concept, investigation on inhibition of meprin β in these mouse models 
could prove functionality of meprin β inhibitors in vivo and display a therapeutic target for 
inflammatory disorders. Moreover, generation of a meprin α over-expressing mouse model could be 
used for identification of novel in vivo substrates and strengthen the role of meprin α in the onset of 
pathological conditions. 
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Appendix 
I  Abbreviations 
ADAM(TS) a disintegrin and metalloprotease (with thrombospondin motifs) 
Adgre adhesion G protein-coupled receptor E2 
α-MSH α-melanocyte-stimulating hormone 
AP-1 activator protein 1 
APP amyloid precursor protein 
α-SMA α-smooth muscle actin 
b bases 
BCA bicinchoninic acid 
BMP-1 bone morphogenetic protein 1 
BTP BMP-1 and Tll1 proteases 
CCL C-C motif chemokine 
CD Crohn’s disease 
CD(99) cluster of differentiation 99 
cDNA complementary DNA 
CFSE carboxyfluorescein succinimidyl ester 
CHO Chinese Hamster Ovary 
Col1a2 collagen alpha-2(I) chain 
C-pro C-pro-peptide 
CRISPR/Cas9 Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated9 
C-telo C-telopeptide 
CTF C-terminal fragment 
Da Dalton 
DAPI 4′,6-Diamidin-2-phenylindol 
ddH2O double distilled water 
DMEM Dulbecco Minimal Essential Medium 
DMSO dimethyl sulfoxide 
DNA desoxyribonucleic acid 
Dnp 2,4-Dinitrophenyl 
dNTP deoxynucleotide 
DPR Dermatopathia Pigmentosa Reticularis 
DSS dextran sulfate sodium 
DTT dithiothreitole 
ECM extracellular matrix 
EGF(R) epidermal growth factor (receptor) 
EMT epithelial–mesenchymal transition 
ER endoplasmic reticulum 
ERK extracellular signal–regulated kinases 
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FCS fetal calf serum 
Fra2 Fos-related antigen 2 
GAG glycosaminoglycan 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
H&E hematoxylin and eosin 
HaCaT human adult low calcium high temperature keratinocytes 
HA-Tag human influenza hemagglutinin-Tag 
hPAEC human pulmonary artery endothelial cells 
HRP horseradish peroxidase 
IBD inflammatory bowel disease 
IL interleukin 
IPAH idiopathic pulmonary arterial hypertension 
KI knock-in 
KLK kallikrein 
KO knock-out 
KRT cytokeratin 
LLC Lewis lung carcinoma cells 
LPS lipopolysaccharides 
MAM meprin A5 protein, receptor tyrosine phosphatase μ 
MAPK mitogen-activated protein kinase 
MB meprin β 
Mca 7-Methyloxycoumarin-4-yl) acetyl 
MEF mouse embryonic fibroblasts 
MeOH methanol 
Mep meprin 
Meprin metalloprotease from renal tissue 
MMP matrix metalloprotease 
MP-EBS Epidermolysis bullosa simplex with mottled pigmentation and noncicatricial alopecia 
mRNA messenger RNA 
mTLD mammalian tolloid 
ND normal diet 
Neg negative 
NTC non template control 
PAGE polyacrylamide gel electrophoresis 
PBS phosphate buffered saline 
PCPE-1 procollagen 1 C-proteinase enhancer 
PCR polymerase chain reaction 
PDGF platelet-derived growth factor 
PEA3 polyoma enhancer activator 3 
PFA paraformaldehyde 
PMA phorbol myristal acetate 
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Pos positive 
qPCR quantitative RT-PCR 
Rpm rotations per minute 
RgpB Arg-gingipain 
RT-PCR reverse transcription polymerase chain reaction 
SDS sodium dodecyl sulfate 
SI small intestine 
TAE Tris base, acetic acid and EDTA 
TAILS terminal amine isotopic labeling of substrates 
TAM tamoxifen 
TBS Tris buffered saline 
TEM transendothelial migration 
TGFβ transforming growth factor β 
Tll tolloid 
TNFα tumor necrosis factor α 
TRAF tumor-necrosis-factor-receptor associated factor 
UC ulcerative colitis 
UV ultraviolet 
wt wildtype 
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